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AIlSTRACT 
Vitamin D has an important ill1munomodulatory prop~rty and also has bcen suggested to 
play an important role in ce llular metaboli sm. Vitamin D receptor (VDR) gene 
polymorphism has al so becn found to be associated with insulin sccretory capacity and 
glucose intolerance. The present study was undertaken to determine genotype of VDR 
gene coml11 on variants in young onset diabetic subj ects of Bangladesh to exp lore its 
assoc ia tion with diabctes and B ce ll secretory capac ity. A total number o f 94 young 
diabetic subj ects and 92 hea lthy contro ls were recru ited. Detailed clinical and 
anthropometri c measurements were recorded . Blood glucose was measured by glucose-
oxidase, lipids by standard methods. C-peptide was est imated by enzyme linked 
immunosorbent assay (ELISA), and insulin secretory capacity (HOMA%B), sensitiv ity 
(HOMA%S), res istance (HOMA-IR) were calculated using !-IOMA Sigma software. 
DNA was extracted using QIAG EN Blood DNA Kit. VDR gene variants [G>T and T>C] 
wcre dcterm ined by PCR-RFLP using restr iction endo nu clease Apa I and Taq I 
respectively. Data were managed using Stati stical Program fo r Soc ial Sc ience (SPSS). 
Unpai red Student 's -' t ' test and Chi-squared tests, as appropriate, were perform ed. C-
peptide level was fo und to be significantly lower 3.297 (p<O.OO I) and !-IOMA%B found 
lower 3.102 (p=0.003). The G>T and T>C genome frequencies (wild, heterozygous and 
homozygous variants) were in the control (0. 183, 0.516. 0.316 and 0.370, 0.522, 0.109 
respectively) and (0. 198, 0.484, 0.319 and 0.484, 00418, 0.090 respecti ve ly) in YDM 
which did not show significant assoc iati on with YDM (p=0.90G and 0.288 respecti vely). 
Gcnotypc frcquency of the marker a lle le did not show significant assoc iation with 
glucose, C-peptide, !-IOMA %S and I R either in Controls o r Y DM subjects except the 
HOM A %B shown to have re latively lower. 
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CHAPTERl 
INTRODUCTION 
INTRODUCTION 
Diabetes mellitus is a complex heterogeneous group of met abo lie condition characterizcd 
by elevated levcls of blood glucose, caused mai nly by impairment of insulin action and 
or insulin secretion (ADA 2005). Diabetes is one of the most prevalent and devastating 
chron ic non-communicab le diseases having serious health, economic and soc ial 
consequences (IOF 2006). Diabetes mellitus, long been consid cred as a disease of minor 
signili canee to world hea lth, however has become one of the main threats to human 
health in the 2 1" century (Z illlmct el ai., 2000). In the past two decades there has been 
an explosive increase in the num ber of people diagnosed with diabetes a ll over the world 
(A mos el al., 1997; King el al., 1998). 
The World Health Organization (WHO) sponsored estimate in 1995 showed total world 
diabeti c subj ects to be 135 million and which however projected that the number wou ld 
increase to around 300 million in the year 2025 (K ing el a i. , 1998) . Subsequen tl y global 
preva lence of diabetes for a ll age-groups was estimated to ri se from 2.8% in 2000 to 
4.4% in 2030 and also demonstrated that total numbcr of people with di abctes is 
projected to rise from 171 million in 2000 to 366 million in 2030 (Wild el al., 2004). In 
Europe, an over all prevalence of diabetes is about 7.8% in the adu lt population (20-79 
years) (IDF 2003). Without effective prevention program of diabetes prevalence in 
Europe is expected to increase to 9. 1 % in 2025 as estimated by the International Diabetes 
Federation (IDF 2003). The number of Americans with diabetes is expected to be a lmost 
double from 18.2 million in 2003 to 30.3 million in 2030 (W ild el a /., 2004). 
Classification of Diabetes of Mellitus 
Diabetes mellitus has long been classifi ed based on its clinical presentation; age of onset 
and special feature, and need for insulin of the individual to control blood glucose. 
Lawrence (1951) was first to introduce the nomenclature type I and type 2 to describe 
two di stinct forms of diabetes mellitus. In late seventies the National Institute of Health 
(N IH), United Slates of America (USA) set up the National Diabetes Data Group 
(NDDG) that formulates thc classifi cation and diagnostic criteri a. The NDDG 
introduced the term insulin dependent diabetes mellitus (100M, Type I) and noninsulin 
dependent diabetes mellitus (NIDDM, Type 2) to describe two main classes of diabetes 
(NDDG 1979) . In the following year a WHO Expert Committee on Diabetes endorsed 
the NDDG proposed classification of diabetes with some modifications especially 
regarding di agnostic criteria (WHO 1980) . According to the present classification of 
diabetes four main c lasses o f the disease are typc I, type 2, Other Specific types and 
Gestationa l Diabctcs Mcllitus (Table I) (WHO 1999 and ADA I 997).Thc other subclass 
was protein defic ient diabetes mellitus (PDDM). Among the young diabetes FCPD was 
found to be 13% and I'DDM 42% (Azad Khan and Ali 1997). The others with BMI> 19 
and diabetes diagnosed at younger age were termed as non insulin dependent diabetes 
mellitus in you ng (N IDDY). 
Table I: Etiolugical C lass ification of Diabetes Mellitus (WHO, 1999) 
A. Type I (beta-cell destruction, usuall y leading to absolute insulin deficiency) 
Type I A- Auto immune mediated type 
Type I B- Non- immune mediated idiopathic type 
B. Type 2 (may range from predominantly insulin resistance with re lative insulin 
defi ciency to a predominantly secretory defect with or without insulin resistance) 
C. Other Specific Types of Diabetes 
• Genetic defects of beta-cell function 
• Genetic defects in insulin action 
• Diseases of the exocrine pancreas 
• Endocrinopathies 
• Drug- or chem ical-induced 
• Infections (Congenital rubella, Cytomegalov irus, Others) 
• Uncommon forms of immune-mediated diabetes 
• Other Genetic Syndromes Sometimes Associated with Diabetes 
(Down's syndrome, Friedreich's ataxia, Turner's syndrome, etc) 
D. Gestational diabetes 
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Type 1 Diabetes Mellitus 
T I DM is characterized by sudden onset of symptoms, proneness to kitoacidosis and need 
of insulin for survival. The hallmark of the T I DM is pancreatic B cell damage resulting 
in very low to absolute loss of insulin secretion. TIDM mainly occur in children and 
young adults and accounts for about 10% of all diabetic patients (ADA 1997). The 
incidence of TI DM was found to be lowest in Asia (0.1 per 1000,000 in China) and 
highest in Scandinavia (3S.S per 1000,000 in Finland). However, there are notable 
exceptions, for instancc the incidence is low in Iceland but in Sardinia, Italy the 
incidence is similar to that of Finland (Karvonen el al., 2000). A report from Southern 
India has shown that these the incidence of TI DM is similar (I O.S/I 000,000) to many 
European populations (Ramachandran e/ aI., 1986). TI DM is believed to be less 
prevalent in Bangladesh, however, population based studies are still lacking. 
TI DM is subclassified on the basis of type of damage of B cells; immune mediated type I 
and non-immune mediated typel (idiopathic type I, TIDM) (ADA 1997; WHO 1999). 
Autoimmune TI DM is characterized by immune mediated damage, targeted against self-
antigens, resulting in the destruction of the B cells of the pancreas. A number of 
autoantibodies have been detected against different islet proteins. The rate of B cell 
destruction is found to vary widely. It has been seen to be usually faster in children and 
slower in adults. A number ofTI DM patients have a typical sudden onset of the disease 
and are ketosis prone. But they lack classical autoantibodies directed to islets andlor islet 
cell proteins and are called idiopathic TI DM. This form of diabetes is thought to be most 
common in African and Asian countries (McLarty el al., 1990 and; Tanaka el al., 2000). 
Idiopathic TI DM usually occurs to obese teens. Once their blood glucose is controlled 
by insulin oral hypoglycemic agents can be subsequently used before the onset of 
complete insulin dependence as in TI DM. While the exact etiological factor( s) are still 
unknown, multiple genetic and environmental factors are thought to be involved (ADA 
1997; WHO 1999). 
In another in depth study, autoantibody and candidate gene markers were investigated in 
young onset diabetic subjects. TI DM diabetes related antibodies; anti Glutamic acid 
decarboxylase (GAD) antibody and anti IA2 antibodies were found to be positive around 
2S% of the study subjects (Hassan el al., 200S). INS-VNTR polymorphism did not show 
any association with diabetes. Although FCPD is suggested to be the secondary type of 
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diabetes according to the present classification. TI DM related auto antibodies were 
found to be positive in 20% of study subjects (Hassan 2006). This suggested diabetes in 
the young subjects of Bangladesh may represent a group ofatypical TI DM. 
Type 2 Diabetes Mellitus 
Type 2 diabetes mellitus (T2DM) is characterized by the presence of disorders of insulin 
action and/or insulin secretion (Reaven 1988). Both defects are usually present in a 
T2DM patient; however, the primacy of the two factors for the development of diabetes 
still rema ins to be clearly understood. 
T2DM constitutes more than 90% of all diabetics and in most populations. However, in 
American Indians and South Pacific Islanders, TIDM is found to be the only form of the 
diabetes. Overall prevalence of diabetes varies between 15-20%. The highest prevalence 
ofT2DM (50%) was found among Pima Indians (49.4% in male and 51.1% in female) in 
USA and Nauru (41%; male 40% and female 42%) and a very low (0-1.4%; male 0% 
and female 1.4%) was observed among the Mapuches population in Chile. The 
prevalence was almost nil in rural and peri-rural population of Papua New Guinea (WHO 
1994). 
Based on recent community based studies the prevalence of diabetes in Bangladesh is 
found to be around 5%. Studies involving rural and suburban population revealed the 
prevalence of TID to be 4.3% and 4.1 % respectively (Sayeed e/ al., 1997 and 2003). 
Pathogenesis of DM 
Diabetes is probably caused by a complex interaction of environmental factors and 
genetic predisposition. Environmental ri sk factors are thought to act as either damage or 
dysfunction among the genetically predisposed subjects. 
Environmental factors 
Despite the strong evidence for environmental trigger in the pathogenesis of TI DM the 
precise pathology still remains elusive. Among the environmental factors implicated in 
the pathogenesis ofTIDM most notable are diet, stress and viral infections (Knip and 
Akerblom 1999; Dahlquist 1998). Early exposure to cow's milk, duration of breast-
feeding and food preservatives, particularly nitroso compound are claimed to be 
associated with the development ofT I DM (Karjalainen e/ al., 1992). 
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Coxsackie virus B (CV13) and rubella have been imp li cated in the pathogenesis ofT I DM 
(Lu kie el ai. , 1992) . However, the pathologica l basis in its development remains to be 
clearly understood. 
Among the environ mental factors in the path ogenesis of T2DM age, physica l acti vity, 
dietary habits, lifestyle and obesity playa crucial role in the mod ulation of development 
of the d isease (Hu el 01., 2003) . Glucose tolerance has been shown to decrease wi th age 
(DeFronzo 198 1; Shimokata el al., 199 1). However, whether the deterioration is caused 
by increased age or seco ndary to agc related ",ctors, such as decreased physica l acti vity, 
is sti ll to be clearl y understood . 
Diffe rence has been observed III the preva lence of TI DM in Europoid popul ations 
between men and women. Some stud ies had shown a higher age-adjusted prevalence in 
women (Oamsgaard el ai. , 1987; Bruno el 01., 1992), whereas other investigators 
demonstrated male preponderance (Lintott el ai. , 1992) . Variation in TIOM preva lence 
between men and women also has been shown to vary in d ifferent age gro up in the same 
commun ity. 
The major environmental risk factors for T2DM are fo und to be obesity (> 120% ideal 
body we ight or a body mass index >30Kg/m) and a sedentary lifestyle (B leich el al., 
2007). Thus, the tremendous increase in the rates of T2DM in recent years has been 
attri buted, primaril y, to the dramatic rise in obes ity worldw ide (Zimmet el al., 200 I). It 
has been shown that approx imately 80% of a ll new T2DM cases are due to obes ity. In 
the Pi ma Indians, 85% of the TIDM children were either overweight or obese (Fagot el 
01. , 2000). Although excess weight anci obesity (BM I>25 kg/m2) acco un t for 64% cases 
of diabetes in men and 74% in women, many cases of diabetes occur in lean subjects as 
well (Chan el 01. , 1994; Cold itz el 01. , 1995). 
The risk for T20M also fou nd to be associated with phys ical activity and a gradient was 
observed between exposure and outcome (Knowler el ai., 2002). Eri ksson et a l (1993) 
has shown that hi gh physical acti vity red uces the progress ion from IGT to T2DM in the 
Sweden population. A low prevalence of T2DM was found in physically active 
japaness-Hawai ian men (Benoist el 01., 1997). In Chinese (Pani el al., 1997) and Indian 
population the progression from IGT to T2DM was also shown to be red uced (Eriksson 
el 01., 1993). 
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Role of vitllmill D ill dillbetes 
Vitamin 0 has been suggested to play important role in the immunomodulation (DeLuca 
el al. , 2004). It has been implicated in the pathogenesis o f TIDM although the 
mechanism is yet to be clearly understood. Severa l studies in rats and humans (Norman 
el al., 1980 and Boucher el al., 1995) have demonstrated vitamin 0 deficiency to reduce 
insulin secretion, and lu2S(OH)zD3 supplementation improve in B cell secretory 
function and consequently in glucose tolerance (Kumar et al., 1994). Glucose tolerance 
and insulin secretion were found to improve in vitamin 0 deficient rat treated with 
lu2S(OH)zD3 treatment (Cade el al., 1997) . Rudnicki and Molsted-Petersen (1997) 
reported fall of glucose to 4.8 from S.6 mmol/l after intravenous treatment with 
IU,2S(OI-I)zD3 in gestationa l diabetes mellitus patients. In a study by Giulietti et al 
(2004), it was demonstrated that vitamin D deficiency in early lifc might increase risk for 
dcvelopment of T I DM. They showed that at 2S0 days, 3S% male and 66% female 
vitamin 0 deficient mice were diabetic compared to IS and 4S% of the control mice . In 
the vitamin 0 deficient mice, higher IL-I expression was detected in islets. Thymus and 
lymph nodes a lso contained less CD4CD62L+ cells; a defect in this cy10kine profile 
might trigger the diabetes. The higher rate of development of diabetes in vitamin 0 
defic ient mice was substantiated by thc obscrvation of Chiu ct al (2004). They have 
demonstrated inhibitor of insulin secretion in vitamin 0 deficient statc. 
Molecular actiou of lu,25-dihydroxyvit:lInin D3 
Not on ly vitamin 0 but a lso its metabolites play important role in regulation of the 
endocrine pancreatic function. The poss ible mechanism is not on ly via the plasma 
calcium levels but also directly on the B cell s. I u,2S(OH)2D3 may influence both 
endocrine and exocrine pancreatic function (Johnson el 01. , 1994). The effects of 
IU,2S(OH)zD3, a biologically active metabolite of vitamin 0 , and its ana logs have been 
examined regarding binding to nuclear VDR (nVDR) and membrane VDR (mVDR) 
receptors, through which they might induce genomic and nongenomic responscs 
respectively. 
Kajikawa et al (1999) stud ied the effect of I u,25-dihydroxyluminesteroI3 
1,25(OH)2IumisteroI3 - an analog of 1,25(OHhDJ that is preferred for its nongenomic 
action through putative signal transduction by binding to mVDR (Dorman en el al., 1994) 
on insulin release from rat pancreatic B cells. They found an insulinotropic effect of this 
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vitamin analog with increasing intrace llular C}+ concentrati on 111 panc reatic B cells 
through nongcnomic s ignal transducti on. There is also cv idcnce that I CL,25(OH),D) 
directly influences insulin secretion in the B cell through a rise in intracellular-free 
calcium concentration via the nonse lective calc ium channel, rather than the calcium 
dependent inos itol 1,4,5-triphosphate receptor-mediated pathway (Sergeev el aI., 1995) . 
lu,25(Ol-lhD) also exerted a stimulating effect on insulin release via protein kinase A 
activation, but reduced the supranormal cyclic adenosine monophosphate (AMP) 
synthesis (Bourlon el al., 1997). I CL,25(OH)2D) may provide supplementary calcium to 
the B cell by rcgulating the intracellular s ignaling processes in volving phospholipids 
metabo lism, protein kinase C induction, Ca2+ mobilization, and Ca2+ entry by Ca2+ 
channels (Billaudel et al. , 1995). 
Norman et al (1993) reported the presence of a vitamin D-<lependent calcium-binding 
protein in pancreas and cytosol receptor for the hormonal form o f vitamin D, I u,25-
dihydroxyv itamin 0 ), suggesting an important role of vitamin 0 in the endocrine 
function of the pancreas. Vitamin 0 deficient rats were unable to respond to a glucose 
challenge by secreting appropriate amounts of insulin (Norman el al. , 1989) since insulin 
release in vivo is dependent on acute change in plasma calcium (<;urry et aI., 1968). 
Glucagon secretion is also ca lcium-dependent (Lundquist et al., 1996), but secretion of 
thi s hormone was unaffected by I CL,25(OH),O) treatment. The genomic actions of 
I u,25(Ol-lhO) on B cells of the endocrine pancreas have been reported. 
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Figure I: Schematic nongenomic model for la,25(OH), D, effects on insulin secretion in B cells 
Calbindin-D28K, a calcium-binding protein that is thought to act as a facilitator of 
calcium diffusion in intestine and kidney is known to be regulated by vitamin D in these 
tissues (Christakos el al., 1989). In cells transfected with Calbindin D28K, there was a 
marked increase in the expression of insulin mRNA. In addition, Calbindin D28K 
overexpression was also associated with an increase in insulin content and release. In 
chicken, pancreatic cells Calbindin D28K is altered with variations in vitamin D and 
mineral status (Kadowaki el al., 1984). 1,25(OH),DJ activates the B cell insulin response 
to glucose in vivo after a delay of 3 to 20 h (Kadowaki el aI., 1985), or after 6-h in vitro 
(Billaudel el al. , 1990), via an improvement of calcium handling occurring after a 4-h 
delay (Billaudel el aI., 1990), increasing both Ca'+ entry by voltage-dependent channels 
and Ca'+ mobilization from Ca'+ stores (Billaudel el al. , 1993). Bourlon et al (1999) 
reported that synthesis of numerous proteins is decreased during vitamin D3 deficiency 
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and is gradually restored by I u,25(OHhD3 repletion in the islets of Langerhans of rats. 
The existence of variable delays for the actions of I u,25(OHhD3 supports the hypothesis 
ofa genom ic action of the steroid on the biosynthesis of several B cdl protein implicated 
in the different steps of the insulin excitation-secretion coup ling. lu,25(OHhD3 causes 
transcriptional activation of the human insulin receptor gene in U-937 human 
promonocytie ce lls (Maestro el al., 2002). 
Gcnctie factors 
Genetic suscept ibility has been implicated in the pathogenesis of both TI DM and T2DM 
diabetes. Tendency of aggregation ofT I DM in families has been observed by different 
researchers (R isch el ai., 1993; Todd and Farrall 1996). The concordance rate for TIDM 
among monozygotic twins found to be higher between 20-71 % compared to that of 
among dizygotic twins (Kyvik el 01., 1995; Redondo el aI., 1999) suggesting strong 
genetic role in its pathogenesis. The human histocompatibility antigen locus has been 
found to be in linkage disequilibrium in substatial number ofT I DM patients (Wolf el 01., 
1983). Later on variation in HLA Class 11 gcne, particularly DQB I and DR4 allele was 
found to be strongly associ at cd with TI DM (Don ner el 01. , 2000; Park el al. , 1998). 
Among other gene locuses found to be implicated with TI DM are in chromosome 4pl5 
(IDDM2 and IDDM4) (Sawicki el 01., 1997; Hayes el al., 1998) chromosome 2q 13 
(IDDM 12), chromosome 2q3-2q34 (IDDM 13) (Morahan el 01., 1996; Larsen el 01., 
1999), chromosome 6q21 (IDDM 15) (Temple el ai., 2000). 
INS gene is located in the IGF2-INS-TH region on short ann of human chromosome II. 
The locus is designated as lip 15. 1 (Powell el ai., 2005). The INS gene has a variable 
number oftendem repeats (VNTR) immediate adjaccnt to the 5' promoter. 
The VNTR polymorphism can be class ified in to two main groups: small class 1 alleles 
(28-44 repeats) and large class 111 allele ( 138-159 repeats) at frequencies of about 70 and 
30%, respectivel y, and class 11 alleles of intermediate size are rare (Stead and Jeffreys, 
2000). Different degrees of association have been reported between the INS VNTR class 
Il lll genotype and insulin-related traits or diseases. The class I allele is associated with 
increased expression of insulin mRNA and insulin leve ls (Lucassen el al., 1995; Bennett 
el ai., 1996; Le Stunff el aI., 2000). The allelic variation ofVNTR is also associated with 
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the risk of d iabetes. It has been fou nd consistentl y that the class I a llele increases the risk 
ofT IOM (J ul ierel al., 199 1; Lucassen el al., 1993). 
CTLA-4 (cytotox ic T lymphocyte-associated 4) gene is located on chromosome 2q3 1-35, 
where multipl e T IOM genes may be located . CTLA-4 gene vari ants have been 
associated with T IOM, as well as other autoi mmune d isease. CTLA-4 is a protein that 
plays a key ro le in T ce ll activation (Barbara Angel el al., 2009) by recogniz ing its 
specific antigen which is presented by an antigen presenting cell in a periphera l 
lymphoid organ, the T cell receives co-stimulatory signals to different iate and pro li ferate 
into armed efTectors T ce lls but the principal co-stim ulatory molecule for activati on and 
clonal ex pansion expressed by T cell s are the C028 receptors. C028 prote ins bind to B7 
molecu les, which are expressed by antigen presenting cells (Janeway el al., 2005). 
Also, subsequent to T cell acti vation, the lymphocyte secretes the cytok ine interleukin-2 
(l L-2), which drives proliferation and d ifferentiation of the cell. Acti vated T cell s express 
a high affini ty for IL-2 receptors, which binds to the cytok ine IL-2. However, it was 
discovered that when CTLA-4 is induecd, it decrcases IL-2 production (A legre el a/., 
1998). The extra cellular domai n of CTLA-4 can be fused with the antibody IgG 
(Freeman el al., 1998). CTLA-4 Ig is a protei n that is ind uced to block the production IL-
2 and C028/B7 co-stimulation (A legre el al. , 1998). 
A meta-analys is was done by Fot ini (2005) of 33 studies exam ining the association of 
T I OM mell itus wi th po lymorph isms in the cytotox ic T -lymphocyte-assoc iated antige n-4 
(CTLA-4) gene, includi ng the A49G (29 compari sons), C (-318) T (three comparisons) 
and (A1) II microsatellite (six comparisons) po lymorphisms. 
TIOM is also fo und to be concentrated in fa milies than in general popu lat ion (Klein el 
al., 1996; Weijnen el al., 2002). Red uced concordance of T20M in both mono-and 
dizygoric twi ns suggested that nongenetic factors, poss ibly environmental trigger the 
deve lopment of this type of diabetes (Newman el al., 1987) . Famil y studies have 
revealed that firs t degree relati ves of individuals wi th T20 M are about 3 ti mes more 
like ly to develop the disease than individuals without a positi ve fa mily history of the 
disease (Hansen 2003; Gloyn 2003). Moreover, T20M mainly resul ts from interaction of 
many genes. Genome wide scan iden tified several chromosomal regions strongly linked 
with TIOM. One approach that is used to identify disease susceptibil ity genes is based 
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on the identification of candidate genes (Barroso et al., 2003; Stumvoll, 2004). Most 
predisposing candidate genes are PPARy (peroxisome proliferator-activated rcceptor-y), 
KCN! II , ABCC8 and CALPN 10 (Cal pain 10) involved in T2DM. 
PPARy gene is an important regulator of adiposite development and lipid metabolism 
(Tontonoz et al., 1994) has become a potential therapeuti c target for the treatment of a 
diversc array o f disorders, incluuing T20M, dyslipidaemia, innammation and 
malignancy. One form of the PPARy gene (Pro) decreases insulin sensitivity and 
increases T20M risk several fold. 
eAPN 10 encodes an intrace llular calcium-dependent cysteine protease that is 
ubiquitously expressed (Cox et al., 2001). A haplotype that was initially allowed to 
TIDM included an intronic A to G mutation at position 43, which appears to be involved 
in CAPNIO transcription. 
Vitamin D reccptor (VDR) genc 
The vitamin D receptor mediates the m:tiority of the effects of vitamin D (as the active 
form lu,25-dihydroxyv itamin D (calcitriol» on gene express ion via formation of a 
heterodimer with the retinoid X receptor which binds to promoter regions of many target 
genes. There are 6 known polymorphisms in the VDR locus with a range of possible 
effects Crable I) (Uitterlinden et al., 2004). 
A number of observational studies have reported on associations (or lack of) between 
VOR polymorph isms and T2DM; fasting g lucose, glucose intolerance, in su lin 
sens itivity, insulin secretion and caleitriol levels. 
Studies have demonstrated a link between VDR polymorphism and T2DM, although the 
findings differ from one population to another. A study involving Bangladeshi 
population demonstrated that the Apa I polymorphism innuenees insulin secret ion in 
response to glucose (I-Iitman et 01., 1998) while association between the VDR Apal and 
higher fasting plasma glucose levels and glucose intolerance were obscrved in a 
community based study of o luer adults without known diabetes (Oh et 01., 2002). 
Subsequently common VDR polymorphism was investigated in another population. In 
this study rather 8sm I polymorphism was fOllnd to be associated with highcr fasting 
glucose levels in young males with low physical activity (Ortlepp et 01., 2003). 
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Table 2: VDR polymorphisms and its association (Uitterlinden el al., 2004) 
Polymorphism Disease and proposcd mcchanism 
Cdx2(G to A) Decreased risk of fracture with A allele increases VDR 
expression in the intesti ne increasing calcium transport 
prot ien transcription leading to increased calcium 
absorption and increased bone mineral density. 
Fok l (424 and 427 amino acid Appears to be functiona l and the 424aa variant is more 
variants) active in terms of transactivation capacity 
3'UTR po lymorph isms (2 Di fference III mRNA expression, leve l of serum 
frequent haplotype and many markers such as osteocalcin 
polymorphism) 
With Fokl one haplotype has higher VDR transcription 
efficiency 
Bsml,Apal and Taql Are in linkage disequi librium with the 3' UTR and 
functi onal ity currently assumed to be due to that 
Diabetes in IJa ngladesh 
At present, prevalence of diabetes me lli tu s in Bangladesh is about 7% (Sayeed el al., 
2007). This rise in prevalence is found to be consistent with the previous WHO estimate 
which has suggested a rise of prevalence of diabetes in Bangladesh like other developing 
Asian countries. 
There is, however, a difference in prevalence of diabetes in urban and rural areas. Sayeed 
et al (2007) have shown that the prevalence of diabetes to be 4% and I I % in urban and 
rural areas respectively. Another study has shown the prevalence to be around 8% which 
also showed male and fema le the prevalence to be 9.8 and 8.0% respect ively (Rahman el 
al., 2007). 
Studies were undertaken also to explore etiopathogenesis of T2DM in the Bangladeshi 
population as well. Study on newly diagnosed normal to overweight T2DM subjects 
reporting that they have both insulin secretory dysfunct ion and insulin resistance but 
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former was found to be predominant in the pathophysio logy of T2DM (AI-Mahmood 
2000). It was a lso observed that the extent of insulin secretory dysfunction was found to 
be more pronounced compared to loss of insulin sensi tivity in obese type 2 subj ects of 
our population (Junaid 2000). In contrast most western people w ith T2DM were 
re lati ve ly obese and had impaired insulin action (Sacks 1999). These studi es have 
demonstrated that insulin secretory dysfuncti on not the insulin sensiti vity is prime 
features of T2 DM of Bangladeshi population. 
Young Diabetes Mellitus (YOM) in Ilangladesh 
A substantial number of patients d iagnosed and registered at BIRDEM are of younger 
age i.e. less than 30 years. T hey acco unt lo r about 7% of patients of a ll ages who are 
registered a BIRDEM termed as young onset diabetes mell itus (Y DM). They are lean, 
normal to moderate over weight, low BMI (BMI < 19) and usua ll y present with moderate 
to sever hyperglycemia. A subset of these diabetic patients has pancreatic ca lc ifica tion 
and/or fib ros is and is termed fibrocalculous pancreatic diabetes (FCPD). In the present 
di abetes c lassification they are c lassifi ed as secondary d iabetes of pancreatic origin under 
other spec ific types of diabetes. However, in the prev ious WHO classification these case 
have been classified as one the two subclass o f malnutrition re lated d iabetes mcll itus 
(MRDM). 
[n the very first of these kinds of stud ies, Islam et a I. , ( 1998) investigated a seri es of 
young onset diabetic patients by glucagon stimulating test. They demonstrated that 
among the lean young subj ects 33% had intermediate secretory capac ity and 67% had 
low capac ity compared to 100% with intermed iate secretory capacity of the normal to 
moderately over weight young diabetic patients. The findings c learly showed that large 
number of lean-young di abetic patients had low B ce ll secretory capac ity. However, they 
were nonketotic at the time of recruitment even with very hi gh serum glucose level 
(I slam el al., 1998). In later a study involving a series of lean under-30 diabetic patients 
insulin sensitivity was assessed by short insulin to lerance test and insul in secretory 
capacity was measured to explore the primary o f defect in the pathogenesis of di abetes. 
The study revea led substantia l reducti on of in sulin secretory capac ity, both in abso lute 
and re lative terms, in these lean young patients (A li el ClI ., 2003). They were not insulin 
res istant compared to age and BMI matched hea lthy controls (B iswas el al., 2003) . 
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Vitamin D itse lf and VDR gene polymorphism have links to the pathogenesis of both 
type I and type 2 diabetes since YDM seems to be representing unique gro ups of 
diabetic patients. An investi gat ion o f VDR gene common polymorphism wou ld help in 
further understanding the development or diabetes in the you ng onset diabetes in 
Bangladesh. 
Hypothesis 
Vitamin D receptor gene common polymorphi sllls are not assoc iated with diabetes 
mellitus in the young of Bangladeshi popu lat ion. 
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Objectives: 
General objectives: 
The general objectives of the study were to determine thc VDR gene common 
polymorphisl11s in the young diabetic subj ects of Bangladesh. 
Specific objectives: 
Thc spec ific objectives of the present study wc re to: 
• Determine VDR gene G>T and T>C po lymorphisms in a group of young onset 
diabetic patients of Bangladeshi origin. 
• Estimate C-peptide level of the study subj ccts to evaluate res idual B cell 
secretory status 
• Explore the re lationship. if any. with B cell secretory status and VDR gcne G>T 
and T>C polymorphi sm of the study subj ects. 
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CHAPTER 2 
REVIEW OF LITERATURE 
Review of Litenlture 
Vitamin D is a group of fa t-soluble mo lecul es that are essentia l for calcium and 
phosphorus absorption in our body. Among the 5 types of vitamin D (vitamin DJ, D2, D3, 
D4, Ds); vitamin D2 (ergosterol) and D3 (cholecalciferol) are the most important and 
essential ones (Walter el ai., 2003). Vitamin D is a generic term and indicates a molecule 
o f the general structure shown for rings A, B, C, and D with differing s ide chain 
structures. The A, B, C, and D ring structure is derived from the cyc lopentanoperhydro-
phenanthrcne ring structure for stero ids. Vitamin D is classified as a seco-stero id in 
which onc of the rings has been broken; in vitamin D, the 9, 10 carbon-ca rbon bond of 
ring B is broken. 
c" I ). ell,.. /c.~ ,....(1'4 " 
d -(./ ........ <. .. 1 (.H 
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Figure 2: The Chemical Structure of Vitamin D (Crowfoot-Hodgkin el al., 1957). 
Source and Metabolism of vitamin D 
Good sources of vitamin D are butter, cheese, cream, yogurt, milk eggs and su nlight. The 
richest sources of vitamin Dare li sh-li ver oils, particularly those o f the ha libut and the 
cod (NIH 20 I 0). 
Few foods naturally contai n or may be fortified with vitamin D. Vitamin D2 is formed 
through the ultravio let irradiation o f ergosterol from yeast, and vitamin D3 through the 
ultravio let irradiation of 7-dehydrocholesterol from lano lin which is called 
cholecalci ferol (Figure 2). 
7-Dehydrocholesterol is the precursor of vitamin D3 and forms cho lecalc ife ro l only after 
being exposcd to solar UV radiation (Bouillon el aI., 200 I; Holick; 2004). 
Cho leca lciferol is then hydroxy lated in th e liver to become calcifediol (25-
hyd roxyv itamin D3). 25-hydroxyvitamin D is metabo li zed in the kidneys by the enzyme 
25-hydroxyvitamin D-I a-hydroxylase (CYP27B I) to its active form, 1,25-
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dihydroxyvitamin D (Holick; 2004). The renal production of 1,25-dihydroxyvitamin D is 
tightly regulated by plasma parathyroid hormone, serum calcium and phosphorus levels 
(Holick; 2004). Fibroblast growth factor 23, secreted from the bone, causes the sodium-
phosphate cotransporter to be internalized by the cells of the kidney and small intestine 
and also suppresses 1,25-dihydroxyvitamin D synthesis. The efficiency of the absorption 
of renal calcium and of intestinal calcium and phosphorus is increased in the presence of 
1,25-dihydroxyvitamin D (Figure 2) (Dusso el 01., 2(05). It also induces the expression 
of the enzyme 25-hydroxyvitamin D-24-hydroxylase (CYP24), which catabolizes both 
25-hydroxyvitamin D and 1,25-dihydroxyvitamin D into biologically inactive, water-
soluble calcitroic acid (Holick el 01., 2(05). 
-SKJN 
25(OH,._ 
(mitoc:toaoa lal CYP27Al ) 
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25(OH)vilumin ~ 
targot tissues/cells 
Figure 3: Synthesis and metabolism of 1a,25-dihydroxyvitamin D3. Vitamin D can 
be obtained from food (vitamin ~ and D:J) or by pbotobiogenesis in the skin (vitamin 
D3)' In the blood, all vitamin D metabolites are bound to vitamin D-binding protein 
(DBP). Vitamin D3 is converted by two successive bydroxylations in the liver (25-
bydroxylases) and kidney (Ia-bydroxylase) into its active bormonal form, 
1,25(OHbD3 (Mathieu el 01. ,2006). 
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Function of Vitamin DJ 
Vitamin D3 maintains the blood calcium level within a narrow range is vital for normal 
functioning of the nervous system, as well as for bone growth, and maintenance of bone 
density. Vitamin D is essential for the efficient utilization of calcium by the body 
(Holick; 2004). Without vitamin D, only 10 to 15% of dietary calcium and about 60% of 
phosphorus is absorbed (DeLuca el al., 2004). The interaction of 1,25-dihydroxyvitamin 
D with the vitamin D receptor increases thc efficiency of intestinal calcium absorption to 
30 to 40% and phosphorus absorption to approximately 80% (Figure 3) (DeLuca el aI. , 
2004; Heaney el al., 2003). 
Bischoff-Ferrari (2006) has shown that serum levels of 25-hydroxyvitamin D were 
directly related to bone mineral density in white, black, and Mexican-American men and 
women, with a maximum density achieved when the 25-hydroxyvitamin D level reached 
40 ng/ml or more (Boonen el al., 2006; Lips el al. , 2001). When the level was found to 
be 30 ng/ml or less, there was a significant decrease in intestinal calcium absorption 
(Heaney el aI., 2003) that was associated with increased parathyroid hormone secretion 
(Thomas el aI., 1998). Parathyroid hormone enhances the tubular reabsorption of 
calcium and stimulates the kidneys to produce 1,25-dihydroxyvitamin D (Holick el al. , 
2006; Dusso el al., 2005). Parathyroid hormone also activates osteoblasts, which 
stimulate the transformation of preosteoc1asts into mature osteoclasts (Figure 3) (Holick 
el al., 2006). Osteoclasts dissolve the mineralized collagen matrix in bone, causing ' 
osteopenia, osteoporosis and rickets in ch ildren and osteomalacia in adults (Holick el al., 
2006) a lso increasing the ri sk of fractu, 'c (Chapuy el al., 1997; Lips e l al., 200 1). If 
vitamin D deficiency progresses the parathyroid glands arc maximally stimulated and 
may cause secondary hyperparathyroidism (Malabanan el al., 1998). 
Vitamin D deficiency results in muscle weakness (Holick el aI., 2006; Bischoff-Ferrari el 
al., 2006; Petti for el aI., 2005). Skeletal muscles have a vitamin D receptor and may 
require vitamin D for maximum Function (Holick el al. , 2006; Bischoff-Ferrari e l al., 
2006). Performance speed and proximal muscle strength were markedly improved when 
25- hydroxyvitamin D levels increased from 4 to 16 ng/ml (10 to 40 nOlo II I) and 
continued to improve as the levels increased to more than 40 ng per milliliter (100 
nmol/I) (Malabanan el aI., 1998). 
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Nonskeletal organ such as brain, prostate, breast, and colon tissues, among others, as 
well as immune cclls have a vitamin D receptor and respond to 1,25-uihydroxyvitamin 
D3 (Holick el aI., 2006; Dusso el al., 200S). In addition, some of these tissues and cells 
express the enzyme 25-hydroxyvitamin D-Ia-hydroxylase (Holick el al., 2006; DeLuca 
el al. , 2004). Both prospective and retrospective epidemiologic studies indicate that the 
levels of 2S-hydroxyvitamin D below 20 nglml are associated with a 30 to SO% 
increased risk of incident colon, prostate, and breast cancer, along with higher mortality 
trom these cancers (Gorham el al., 200S; Giovannucci el al., 2006). An analysis from the 
Nurses' Health Study cohort (32,826 subjects) showed that the odds ratios for eolorectal 
cancer were inversely associatcd with median serum levels of 2S-hydroxyvitamin D (the 
OR at 16.2 nglml [40.4 nmol/I] was 1.0, and the odds ratio at 39.9 nglml [99.6 nmol/l] 
was 0.S3; p :00.01). Serum 1,2S-dihydroxyvitamin D levels were not associated with 
colorectal cancer (Giovannucci el al. , 2006). 1,2S-Dihydroxyvitamin D is also a potent 
immunomodulator (Penna e l al., 2005). 
Vitamin D deficiency found to be associatcd with congestive heart failure (Zittennann e l 
al., 2006) and blood levels of inflammatory factors, including C-reactive protein and 
interleukin-IO (Zittennann el al., 2003). Patients with hypertension who were exposed to 
ultraviolet B radiation three times a week for 3 months, 2S-hydroxyvitamin D levels 
found to be increased by approximately \80%, and blood pressure became nonnal (both 
systolic and diastolic blood pressure reduced by 6 mm Hg) (Gorham el aI., 200S). The 
1,2S-dihydroxyvitamin D3 [1 ,2S(OHhD3] , has been shown to inhibit the development of 
autoimmune diseases, including inflammatory bowel disease (IBD) (Margherita el al., 
2004). 
Low dietary vitamin D intake or vitamin D levels found to inversely related to glucose 
intolerance, insulin resistance, decreased insulin secretion and found the associations 
between VDR gene polymorph isms and T2DM have been sparse and yielded 
inconsistent (Yiqing el al., 20 I 0). 
Vitamin D deficiency was linked to IGT and T2DM in humans for sometimes (Chiu el 
al., 2004). These obscrvations wcre confirmed in animal model, which dcmonstrated that 
pancreatic insulin is inhibited by vitamin D deficiency (Norman el al., \980). Several 
rcports have ascribed an active role of vitamin D in the functional regulation of the 
endocrine pancreas, particularly the B cells. Not only are receptors for 1,25-
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dihydroxyvitaminD3 found in B cells (Lee el al., 1994), but the effectors part of the 
vitamin D pathway is also present in the form of vitamin D dependent calci um-binding 
protein, also known as ca lbindin-D28K (Sooy el al., 1999). The expression of ca lbindin 
D28K has been shown to protect B cell s from cytokine mediated cell death (Rabinov itch 
el ai., 200 I). 
Vitamin D3 has been suggested to play important ro le in mod ulation of immune process. 
Destruction of B cells in pancreatic islets in T I DM is hi ghl y se lective. Prescnce of 
T I DM related autoantibod ies strongly linked an invo lvement of auto immune 
mechani sm. Several cellular effector mechani sms possibly leading to B cell destructi on 
have been iden ti fied , ineluding CD4+ and CD8+ T cells and macrophages (Bcnoist el al., 
1997) . Epidem io logica l studies have shown an incrcase in the d isease incidence when 
vitamin D deficiency was present in the first month o f life in children. Moreover, in a 
recent study in NOD mice, vitamin D deficiency accelerated the onset of T I DM 
(Giul ietti el al., 2004). In lact, when 1,25-(01-l)2D3 was admini strated at 3 weeks of age 
before the onset of insulitis, it effect ively prevented the progression of diabetes in NOD 
mi ce. However, treatment was incffective if admin istrated at 8 wk of age when insulitis 
was well established (Mat hi eu el al., 1994). 
Supplementation of vitamin D during prcgnancy rcduces the development of islet 
autoantibodies in offspring (Chiu el al., 2004) . A cohort of chi ldren in Fin land were 
given 2000 IU of vitamin D3 per day during their first year of life and fo llowed for 31 
years. In this children found to reduce by approximately 80% (RR, 0.22; 95% C I, 0.05 to 
0.89) (I-Iypponen el al., 200 I). Among chi ldren wi th vitam in D deficiency the ri sk was 
increased by approximately 200% (RR, 3.0; 95% CI, 1.0 to 9.0) . Ch iu et a l (2004) has 
shown that vitamin D defic iency increased insulin res istance, decreased insulin 
production, and was associated with the metabolic syndrome. Another study showed that 
a combined daily intake of 1200 mg ca lc ium and 800 IU of vitamin D lowered the risk of 
T2DM by 33% (re lati ve risk, 0.67; 95% CI, 0.49 to 0.90) as compared with a daily intake 
of less than 600 mg ca lc ium and less than 400 IU vitamin D (Pittas el al. , 2006). Vitamin 
D deficiency has been shown to im pair insulin synthesis and secretion in humans and in 
anima l models of diabetes, suggesting a role in the development o f T2DM (Mathieu el 
ai., 2006). 
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Multiple sclerosis (MS) is a chronic inflammatory autoimmunc disease o f the ccntral 
nervous system (CNS) in which sc lf-ep itopcs on myelinated nerve fibers is in 
appropriate ly rceognized by adaptive immune cells of the host (Yoshiko et aI., 2002). 
The ensuing immune responsc recruits T ce lls and macrophages into the CNS, resu lting 
in localized areas o f inflammation and dem ye lination known as MS les ions. Se lf-antige n 
reactive T helper I (Th I) cells ha ve been demonstrated to play an essential role in both 
induction and effective phase of disease . Th I ccl l diffc rentiati on is controlled by both 
antigen stimulation and cytok incs, particularly IL- 12 and IL-23, which subseq uently 
induce synthesis of Th I-spec ific transcription factor, T-bet, and drives ThO cc lls toward 
Th I differentiat ion (Szabo et aI. , 2000) . T herefore, contro lling Th I development by 
inhibiting IL-12 production will benefit the Th I-mediated disease, such as MS. VDR 
ligands have been shown to inhibit IL-12 p70 prod uction in freshly iso latcd human 
monoeytes that arc primed with IFN-i and stimulated with lipopolysaccharide in a dose-
depcndent man ner. Women who ingested more than 400 IU of vitam in D per day had a 
42% reduced risk of develop ing multiple scleros is (Munger et ai., 2004)_ 
Rheumatoid arthriti s one of the most common chroni c inflammatory diseases, affects 
about I % of thc population and is characterized by articular in fil tration of neutroph il s, 
mac rophagcs, T and B ce lls, and Dendritic Ce lls, resu lting in subsequent ti ssue damage 
(Fe ldman et ai., 1996). Immunization of mice with type II co ll agen found to induces 
arthritis, which was shown to be prevented by dietary supplementation or oral 
administration of 1,25-{0I-lhD3 In both mouse and rat (Tc tl ow et aI., 1999). 
Epidcmiologica l studies havc repol1cd low serum levels of vitam in 0 and its mctabo li tcs 
in RA pat ients (Kroger et ai., 1993)_ Vitamin 03 has bcc n detceted in sy novia l fluid of 
arthriticjoints, and the expression ofVDR has a lso been reported in rheumatoid synovia l 
tissue and at thc si tc of cartilage erosion . Matrix meta ll oprote inases (MMPs) play an 
importan t role in the chondrolytic process of rhcum atoid les ion (GcrstenfeId et aI., 1990) . 
Animal studies have shown that the production of some MMPs may be up-regulated in 
rat chond rocytes by administration of 1,25-(O H120 3 (Gerstenfe ld e{ ai., 1990) . 
Thercfore, VOR ligand can suppress both the I L-Ill-stimu lated production of MMP and 
PGE2 in rhcumatoid synov ial fibroblasts, suggesting that VOR-mcdiated biological 
processes arc important in controlling RA (Tctlow et ai., 1999). 
Vitamin D defic iency is charaetcrizcd by inadeq uate mineralization or demineralization 
of the skeleton. It is also called hypovitaminosis D. Inadequate mineralization of the 
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skeleton causes of rickets in children while demineralization of the skeleton results in 
osteomalcia in adults. Due to vitamin D dcficiency, the bones become weak and the legs 
begin to bow down due to the body's pressure exerted by the weight. As the vitamin D is 
in deficit, the bone tissues do not mineralize, which makes them son and deformed 
(Hollis el aI., 2007). Today it is largely found in low-income counties in Africa, Asia or 
the Middle East and in those with genetic disorders such as pseudovitamin D deficiency 
rickets (Suda el aI., 1992). Osteoporosis is similar to rickets. However, this medical 
condition is seen as vitamin D deficiency symptoms in adults. It is a disease of the bone, 
wherein the bones become prone to fractures. Osteoporosis occurs due to lack of vitamin 
D metabolism leading to poor calcification in bones. Due to low vitamin D in the body, 
the bones become soft and brittle. Osteomalacia is a bone-thinning disorder that occurs 
exclusively in adults and is characterized by proximal muscle weakness and bone 
fragility. The eflects of osteomalacia arc thought to contribute to chronic musculoskeletal 
pain there is no persuasive evidence of lower vitamin D status in chronic pain sufferers 
(Fukumoto el al., 2007). 
Vitamin D deficiency has been linked to an increased incidence of schizophrenia and 
depression (McGrath el aI., 2002; Gloth el al., 1999). Maintaining vitamin D sufficiency 
in utero and during early life, to satisfy the vitamin D receptor transcriptional activity in 
the brain, may be important for brain development as well as for maintenance of mental 
function later in life (Eyles el al., 2005). Vitamin D deficiencies during pregnancy arc at 
increased risk for wheezing illnesses (Camargo el aI., 2007). 
Vitamin D intoxication is extremely rare but can be caused by inadvertent or intentional 
ingestion of excessively high doses. Doses of more than 50,000 IU per day raise levels of 
25-hydroxyvitamin D to more than 150 ng/ml (374 nmolll) and arc associated with 
hypercalcemia and hyperphosphatemia (Holick el aI., 2006; Vieth el al., 2004). Doses of 
10,000 lU of vitamin D3 per day for up to 5 months, however, do not cause toxicity 
(Vieth el 01., 2004). Vitamin D toxicity (hypervitaminosis D) induces abnormally high 
serum calcium levels (hypercalcemia), which could result in bone loss, kidney stones, 
and calcification of organs like the heart and kidneys. The hypercalcemia associated with 
hypervitaminosis D may cause multiple debilitating effects. Anorexia, nausea and 
vomiting have been observed in hypercalcemic individuals treated with 1,250 to 5,000 
micrograms (50,000 to 200,000 lU)/day of vitamin D. Patients with chronic 
granulomatous disorders are more sensitive to serum 25-hydroxyvitamin D levels above 
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30 ng/ml because of macrophage production of 1,25-dihydroxyvitamin 0, which causes 
hypercalci uria and hyperca lcemia (Holick el aI., 2006). 
Vitamin D Receptor (VDR) gene varia nts 
Vitamin 0 is mediated through a nuc lear transcription factor known as the vitam in 0 
receptor (VOR) (Schuster el aI., 2001). Upon entering the nucleus of a ce ll , 1,25-
dihydroxyv itamin 0 assoc iates with the VOR and promotes its associa ti on with the 
retinoic acid X reccptor (RXR). In the presence o f 1,25-dihydroxyv itamin 0 the 
VORlRXR complex binds sma ll sequences of DNA known as vitam in 0 response 
elements (VOREs) and initiates a cascade o f mo lecu lar interactions that modu late the 
transcription of specific genes. 
VOR prote in consists of 427 amino acids, wi th a mo lecular mass of -48 kDa. VOR can 
be d ivided by function into several domains (Figure 4). At the amino terminus there is an 
Al B domain 20 am ino ac ids long. DNA-bind ing domain (DB D), term ed a lso C domain, 
locates between amino acids 2 1 and 92. Do l' nexib le lin ker region locates approxi mately 
bctween am ino acids 93 and 123, fo llowed by the E- or legend-binding domain between 
am ino acids 124 and 427 (Jones el al., 1998). 
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Figure 4: Model or the vitamin D receptor (VDR) (Danie l el al., 2009). 
The human VOR is a product o f the single chromosomal gene that locates on 
chromosome 12; locus 12q 13-1 4 (Labuda el al., 1992). The gene is comprised of II 
e"ons that, together w ith intervening introns, an approximately 75 kb. The noncod ing 5"-
end of thc gene includes 3 exons I A, I B, and I C. Eight add itiona l cxons (exons 2-9) 
encode the structura l port ion of the VOR gene product. Three VOR mRNA transcripts 
are synthes ized depending on how exons I A, I B, and I C are spliced during 
transcription, The promoter sequence lying upstream of exon I A is GC rich and does not 
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contain an apparent T A TA box. A unique feature For the VOR gene is an additional exon 
(V) that is not found in other nuclear hormonc reccptor gencs. It codes an insertion 
peptide about 40 amino acids long that locates in the LBO of reccptor (Miyamoto el al., 
1997). Four common allelic variants of the VOR gene have been identificd and they are 
genetic risk for TI OM. Fokl, Bsml , Apal and Taq l restriction sitc polymorphisms occur 
in exon 2, the intron between exons 8 and 9 (Bsml and Apal) and exon 9 respective ly 
(Deluca el al., 2004). Vitamin 0 and its receptor complex as a transcription factor playa 
regulatory role in B cell insulin secretion (Lee el aI., 1994). The VOR was found to 
express in pancreatic B cells (Johnson el al., 1994) . 
. ---------------------------------------------------------------. 
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Figure 5: Exon- intron structure of the VDR gene (on chromosome 12q I3.1 ) and posi ti on of 
known polymorph isms (Uitterlinden el al., 2004). 
Diseases :Issocilltcd with VDR gene v:lriants 
Variants of the nuclear vitamin 0 receptor (VOR) gene were found to be associated with 
TI DM and thyroid autoimmunity disease. Pan i et al (2002) have shown that the VDR 
genotype is associated w ith Addison's disease. Thcy have Found that the 'rr (13.7% vs 
5.5%; p=0.0243; OR = 2.75) and the 'tt' (28.4% vs 14.1%; p=0.0043; OR = 2.42) 
genotypes were significantly more Frequent in paticnts (n=95) th an in controls (n=220). 
Haiyang et al (2009) have shown that Apal, Bsml and Fokl polymorph isms in the VOR 
gene were associated with susceptibility to Graves' di sease in Asian populations, while 
Apal, Bsml, Taql and Fokl polymorphisms were not associated with the condition in 
Caucasian populations. Bsml polymorphism in the VOR gene was found to be associated 
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with Parkinson's disease in Koreans (Kim et al., 2005). Two VD R polymorph isms (Tag I 
and Fokl RFLPs) in determining Prostate cancer (PRCa) risk in patients with benign 
prostatic hypertrophy (BPH) in Scotti sh population. 
Po lymorphism of the vitamin D reccptor (VDR) gene, which was considered to regulate 
bone metabolism, aroused considerable interest as a risk factor for osteoporos is (Tobin et 
aI., 2004). Bennett et al (1996) have reported that the VDR gene polymorphism of related 
to the occurrence of tuberculos is and infecti on of chronic hepatitis B virus. This may be 
interpreted to indicate a close re lationship between VDR gene po lymorphi sm and the 
immunological action, because vitamin D activates monocytes, stimulates ce ll-med iated 
immunity, and suppresses lymphocyte proliferation. VDR gene po lymorphism (IT 
genotype) found to be a ri sk factor for chronic periodontitis (CP), independently of 
smoking and diabetes (Yo ichi et aI., 2003). A case control study was perfo rmed on a 
group of 168 unrelated Japanese subjects ages ranged from 35 to 65 years. The Tag I 
polymorph ism in the VDR gene was fo und to be significantly associated with CP (X2 = 
4.48, P = 0.034). They performed multiple logistic regression analyses on the IT 
genotype, which was found to be assoc iated with CP, and on well-recognized ri sk 
factors, smoking and diabetes. 
Vitamin D defic iency suggested enhanc ing the preva lence of T2DM and the replacement 
of vitamin D may increase the secretion of insulin (Lee et al., 1994). This impairment is 
primaril y caused by the d ircct effect of vitamin D defic iency on the beta cell, but other 
effects of vi tamin D defi c icncy, such as im pa ircd food intake and hypocalcaem ia, might 
a lso playa rolc. Data from VDR knockout mice we re howevcr, connicting, with some 
groups reporting IGT (Zeitz et aI. , 2003) and others reporting no impairment in g lucose 
metabolism (Mathieu et aI., 2001). The findings, however, suggested that genetic 
background of VDR knockout stra in might be of critica l importance. 
Vitamin D rcceptor (VDR) polymorphism found to be related to TI DM (Pani et ai., 
2000; Chang et ai., 2000). In the nonobese diabetic mouse model for insulin-depe ndent 
diabetes mellitus, vitamin D is necessary for normal insulin release and maintenance of 
glucose to lerance (Mathicu et al., 1994). Reccntly, described the assoc iation between 
a llelic variants of the VDR gene and impaired insulin secretion in T IDM and T2DM 
(McDermott et 01., 1997; Pani el ai., 2000; Chang el ai., 2000). Bsml po lymorph ism was 
shown to be associated with TI DM in South Ind ians (McDermott et ai., 1997) and 
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combinations of BsmIlApaI{faqi found to influence susceptibility to TIDM among 
Germans (Pani el al. , 2000). In a Taiwanese population, the AA genotype of Apal 
polymorphi sm was found to be associated with 1'1 DM (Chang el al., 2000). The aa 
genotype, however, was found to be associated with defective insulin secretion in 
Bangladeshi Asians, a population at increased ri sk for T2DM (Gyapay 1994). In 93 
Southern Indian families with 1'1 DM, transmission disequilibrium testing analysis 
demonstrated the preferential transmission of the " b" allele of the Bsm I polymorphism 
to affected subjects (Pani ef aI., 1997) . However, it was less certain that for the Taq I and 
Apa l polymorphism in the sample set. This study indicates that the Bsml polymorphism 
at the VDR gene locus is a risk factor of TI DM. In a study of 152 Caucasian families 
with TIDM, there was an excessive transm ission ofTaq l and Apal alleles alone (Pani el 
aI., 2000). Vitamin D receptor a llele combinations influence genetic susceptibility to 
TID in Germans. Recently it was confirmed the assoc iation of this marker o f Taiwanese 
population (Chang ef al., 2000) . These two studies in two different populations indicate 
that Bsm I polymorphism at the VDR gene 10C Ll S confcrs susceptibility to 1'1 OM . Studies 
have demonstrated a link between VOR gene polymorphisms and T20M, although the 
findings differ from one population to another. A study in Bangladeshi Asians 
demonstrated that the Apal RF LP influences insulin secretory capacity of the B cells in 
response to glucose (Hitman ef aI., 1998) while assoc iations between the VOR Apal 
RFLP and higher fasting plasma glucose levels and glucose into lerance wcrc observed in 
a community-based study of o ld er adults without known di abetes (Oh ef al., 2002). 
Ortlepp ef al. , (2003) shown th at the genotyp ing for Taql, Apal, 8 sml and Fokl RFLPs 
revealed that the Bsml RFLP is associated with high fasting glucose levels in youn g 
males with low physical activity. 
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CHAPTER 3 
SUBJECTS AND METHODS 
SULIJECTS AND METIIODS 
Place of the study 
The study was conducted In the Biomedical Resea rch G roup (BMRG) laboratory . 
Research Division. Bangladesh Institute or Research ancl Rehabilitation in Diabetes, 
Endoc rine and Metabolic Diso rders (B IR DEM). Dhaka. l3ang ladesh. 
Study period 
Th is study was do ne during the period of June 2009 to Feb ruary 20 I O. 
Study desigu 
This was a case control study. Variant all ele was takcn as exposure facto r. 
Subjecls 
Ninety lo ur (94) hea lthy subjects under 30 years or age search as control and 92 (nine ty 
two) subj ects consecutively attendin g the out-patient dc partmcnt o f B I RDEM, the centra l 
in stitute of Bangladesh Diabetic Associat ion (BADAS) were recruited. 'rhe subjects 
inc luded different raccs, reli gions and soc ioecono mi c statu s. Diabe tes was diagnosed 
following WHO criteria (WHO I999). 
Detail med ica l and c linica l hi story was reco rd ed in a predesigned case record fo rm 
(Append ix I). 
1Ilcll/~'ioll Cl'iteria 
• 
• 
Age or th e subject' s :0:30 years. 
Duration o r diabetes < 3 months. 
ExciU.I'itlll Criteria 
• Subjects with co-morbid di seascs (i nfection, stroke. myoca rd ia l ini(l rct ion, major 
surge ry, esse ntial hype rtension, ma labsorpt ion etc.) we re exc lu ded. 
• 
• 
Subjects w ith hi story 0 1' medi cati on whi ch may s ignificantl y affect glucosc 
metabolism (g lucocorti co id s, oral conlraceptives conta ining; levonorgcstral or 
high-dose estrogen, phenytoin, hi gh-dose thiaz ide d iuretics etc .) we re excluded. 
Pregnant women were exc luded. 
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Anthropometric mcasurClllcnts 
fleig/II (11/) 
Standing he ight was measurcd us ing appropriate sca les (Detect-Medic, Detect sca les 
INC, USA) fo llowing standard procedure . Height was reco rded to the ncarest 5 nll11. 
Weigllt (/ig) 
The balance was placcd on a hard nat surface and chccked for ze ro ba lance before 
measurement. The subj ects were in the ce ntcr o f the platform wea ring li ght c loth s 
without shoes . Weight was recorded to the nca rest 0. 1 kg. 
Calculalion of BM! (kg/II /). 
Body mass indexes (BM I) of the subj ects werc ca lcul atcd using fo ll owin g formula 
I Jlaist circumferellce (elll) 
BMI~ Weight(kg) 
[Height (m))' 
Waist c irc umference was measured to the nearest 1m with a so rt nOll -c lastic measuring 
tape. The tape was SIlU g, but not so ti ght as to ca use sk in inde ntati on or pinchin g. The 
wai st circumference was taken to the nearest standin g hori zontal c ircumference between 
the lower border of the 12th rib and the highest po int of the iliac crest on the mid-ax ill ary 
line at the e nd of nol'l11al exp iration. 
MAC (11/1/1) 
Mid Upper Arm Circ umlcrence (MAC) was mcasured at a po int mid way between the 
acrolll inl process or scapula and olecranon process or ulna of righl ann hanging rel axed. 
A measuring tape was used to record the circ umlerence follow ing the above techn ique at 
the nearest mill i meter. 
Skill foltllllickllen' (11/11/) 
Skin fold thi ckness was measured using Harpenden Skin fo ld Ca lipers fo ll owing standard 
procedure. Triceps ski n fo ld thickness was measu red I c m above the mid poin t between 
the acromi al process o f scapula and o lecra non proccss o r uln a at mid- line postcri o rl y 
wit h skin 10 ILl ly ing along th e long axi s or ri ght ann hanging rela xed. Subscapular skin 
fo ld thi ckness was measured I cm bellow the infe ri or angle o f ri ght sca pula with skin 
fold lying at45 degree. Va lues were rccorded at the nearest mill imctcr. 
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Measurement of blood pressure 
Blood pressure was measured in sitting pos ition. with ca lf at the level orthe hearl. After 
10 minutes of rest a second reading was taken. Recordcd KorotK0!T sound I (the first 
sound) and V (the di sappearance of sound) denoted th e systoli c blood pressure (SBP) 
and diasto lic blood pressurc (DI:lP). respectivel y (WI-IO- IHS). 
METHODS 
Collec/iol/ of blood samples 
Overnight fasting (8-10 hours) blood was co llected betwecn 8.00-9.00 am. Venous blood 
( 10 ml) was obta ined by vcnepuncture following standard procedure. A portion of blood 
(5 ml) sample was taken into a tubc containing EDTA ( I mg!ml). mi xed thoroughly and 
preserved at -30"e IeI' ruture DNA extraction. The other porti on or blood sample was 
taKen into plain tube und allowed to clot Ie I' 30 minutes and serum was separated by 
centrifugation for 10 min at 3000 rpm using refrigcrated centrifuge and preserved at -
300 e for further biochemical ana lyses. 
Biochemical methods 
Estimation of Glucose 
Scrum glucose was estimatcd by enzymatic co lorimctri c (GOD- PAP) method in the 
Hitachi 704 Automatic Analyzcr. Hitachi Ltd .. Tokyo. Japan using reagcnts of 
RANDOX Laboratories Ltd .. UK. 
Pril/ciple 
Glucose is deteJ'lnined aftcr enzymatic ox idation in the prcsence of glucose ox idase. The 
hyd rogen perox ide formed reacts with phenol and 4-aminophenazone under catalys is of 
perox idase to form a rcd violet quinoneim ine dye as indicator (Trinder. 1969). 
Glucose + H,O 
Glucose 
Oxidase Gluconic acid + H,O, 
21-1,0, + 4-aminophenazone + phenol Peroxidase) Quinoneimine + 41-1 ,0 
RcagcII6' 
Conten ts 
Bu ffcr 
Phosphate Buller 
Phenol 
GOD-PA P Reage nt 
4-al11 i nophenazo ne 
Glucose oxidase 
Pc rox idasc 
Standa rd 
Glucose 
Additiona l Reagent 
Urany l Acetate 
Procedure 
Ini tia l concentration of so lu tion 
0. 1 111 01/1, pH 7.0 
I I molll 
0.77 ml110l/l 
~ 1 .5 kUII 
~ 1.5 kUII 
5.55 I11mol/ l ( 100 mg/dl) 
0.16% 
The mcthod determines glucose without deprotein ization. The instrument was ca li brated 
before estimation. Serum and reagents were takc n in spec i!i e cup. Thcse we re arranged 
serially into the Auto analyze r. The Auto anal yzer was programl11 ed lo r th e estil11ation of 
glucose and a llowed to run with lo ll ow ing proceuure: 
5 ~t1 sample and 500 ~I reagent we re mi xed and incubated at 37" C for 10 minutes. The 
reaction OCCUITCU in reactiun cdl or cup. The absorbance of the sample and the standard 
aga inst the reagent blank we re measured at 500 nl11 within 60 minutcs. 
CalClIlalioll of rem/l 
Opt ical densities or absorbances were Icd into a cO l11putcr and calculation was done 
using the so lhvare program . Va ilies lo r the un known samples were ca lculated by 
extrapolating the absorbance For the standard using lo ll owing fo rmula . 
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!ISHII/pit! 
Glucoscconccntrat ion (mmol/ I) = A x 5.55 SlIImftll'l l 
Estimation of Total Cholesterol 
Total cholestero l was mcasured by enzymat ic endpoint method (cholesterol 
Oxidase/Peroxidase) method in auto analyzer Auto ana lyzer HITACHI 704, Hitachi Ltd 
Tokyo, Japan. 
Prillciple 
Cholesterol was determined aftcr enzymatic hydrolysis and ox idation. The indicator 
quinoneimine is formed from hydrogen peroxide and 4-aminoantiphyrine in the presence 
or phenol and peroxidase (Richmond. 1973). 
Cholesterol ester + H,O 
Chole.l'/erul 
ESlerose -----'= =-~) Cholesterol + Fatty acids 
Cholesterol + 0 , 
Choles/erol 
Oxidase 
----"=="-------:> 
2H,O, +phenol+4-aminoantiphyrine 
Reagelll,\' 
Contents 
4-Am inoantipyrine 
Phenol 
Peroxidase 
Cholesterol esterase 
Choleste ro l ox ides 
Pipes Buffer 
Standard 
Cholestene- 3-one + H,O, 
Peroxidase) Quinoneimine + H,O 
Initial Concentration of So lu tion 
0.30 mmol/ I 
6 mmol/ l 
~ 0.5 U/ml 
> 0. 15 U/ml 
> 0. 1 U/ml 
SO 111111 01/1: pH 6.8 
5.1 7 mmol/ l (200 mg/dlJ 
3 1 
Procedlll'e 
Serum and reagents were taken in specific CLIp or ce ll. The se were arranged serially. 
Then ID number for each test was entered in thc Auto analyzer. Five microliller sample 
and 500 pi reage nt were mi xed and incubatcd at 370C for 5 minutes within the Auto lab. 
The reaction occurrcd in reaction cell or cup. Thc absorbance of the sample and the 
standard against the reagen t blank wcre mcasured at 500 nm within 60 minutcs. 
Ca/ell/alion of re~'I1/l 
Concentrati on of chok stcrol in sC1mpk was ca lculated by using so nwarc program with 
the following formula. 
Cholcstcrol concentration (mg/d l) = A Swllple x concentration of standard. 
A S/(Illdord 
Estimation ofTriglyccridc 
Serum triglyce ride was measured by enzymatic co lor imetri c (GPO-PAP) mcthod in thc 
Hitachi 704 Automatic Analyzer. Hitachi Ltd .• Tokyo, Japan using reagents of 
RANDOX Laborator ies Ltd .. UK. 
Principle 
The triglyceride is determincd aftcr enzymatic hyd rolysis with lipases. The indicator is a 
quinoneimine form ed from hydroge n- peroxide, 4- aminophcnazone and 4-chlorophenol 
under the catalytic influence of peroxidase (Fossat i and Prencipe, 1982). 
Triglyceride + H,O 
Gll'ceml 
Glycerol + ATP ---,A,-"""""",,,,-,"_ : 
Lipase> Glycerol + Fatty acids 
Glycerol-3-phosphate + ADP 
Glycerol 
Phospl/ale 
Oridase Glycerol-3-phospI18te +0, ---'==~--> Dihydroxy acetone phospllate + H,O, 
2H,O, + 4-aminophenazone +4- chlorophenol Peroxidase Q' .. Hel H 0 > UII10nelmine + +4, 
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Rcagcnts 
Contcnts 
Buffer 
Pipes Buffer 
4-choloro-phcnol 
Magncsi lim-ions 
EnzYllle Reagent 
4-aminophenazonc 
ATP 
Lipases 
Glycerol-3-phosphate ox idase 
Pcroxidase 
Standard 
Procedllre 
Concentrations in thc Test 
4011111101/1, pH 7.6 
5.5 11111101/1 
17.5 11111101/1 
0.5 mmolll 
1.0 ml110l/ l 
> 150 UiI11I 
1.5 U/ml 
0.5 UiI11I 
2.29 111111 0111 (200 mg/d l) 
Serum and reagents were taken in spec ific Clip. They were arranged serially. Then ID 
nUlllber for test was entered in the analyzcr. Five (5) fl l sa l11ple and 500 fll reagent were 
mixed and incubatcd at 37"C lo r 5 minutes w ithin the ce ll . Reading was taken at 500 nm. 
ClI/CII/lIlioll ()fre,·,t11 
T ri glycer ide conccntration was ca lculatcd by lo llowing formula: 
A SlIlIIJlle 
Triglyceride concentrati on (mg/dl) = x Concentrat ion o f standard. 
il Swl1dord 
Estimation of high dcnsity lipoprotein (1II)L) cholesterol 
Scrul11 High density lipoprotein cholestero l (1-IDLc) was mcasurcd by enzymat ic 
colomctric method using reagent o f Randox laboratories, UK. 
33 
Principle 
I-IDL (High Density Lipoproteins) is separated from chylom icrons, VLDL (ve ry low 
density lipoproteins) and LDL (Low density lipoproteins) by precipitating reagent 
(phosphotungsti c acid-magnesium chl oride) . Allcr centrifugati on. the cholcstcrol 
contcnts of HDL Fraction. which rcmains in the supernatant. lVas dctermined by the 
cnzymatic co lorimetri c mcth od using CHOD- PAP (f'ricdwald el a/., 1972). 
Materia!.'" lIlId ,.e({gellf~· 
I. Precipitant Bu ller 
2. Lipid Controls 
3. Randox aq ueous Cholestcrol Standard : 200 mg/dl 
4. Reagcnt so lution for cholcstcro l CHOP-PAP assay . 
5. Pipcttes (5 Ill - 50 fd, 100 fd-I 000 fd) and Pipettc Tips. 
6. Multi-Channel Pipcttcs and Pipctte Tips: 50-300 ,II 
7. Bufrer and Rcagc nt Reservoirs 
8. Vortcx Mixture 
9. Deionized Water 
10. Microtiter Plate Reader capable orread in g absorbency at 450 nm 590 nl11 
II. Orbital Microtiter Plate Shaker 
12. Absorbant Paper 
Reagents composition: 
Phosphotungstic Aeid: 0.55 11111101/1 
Magncsiul11 Chl oride: 25 mmolll 
Stll/lIll1l'd Preparatioll 
Di lute Randox aqueous cholcsterol standard (200I11g/dl) with deionized water by vo lume 
of 0, 20, 40. 50. and 100 ,d. The final vo lumc was 200 Iti. 
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A.~.my Procedure 
I. 100 ml serum sample take n in microcentriruge tube 
2. Add 250 ~t1 HDL-c Precipitant. 
3. Mix well and allow silting 1'01' 10 minutcs 
4. Vortex the mix components and cen trifuged 1'01' IS minutes at4000 rpm . 
5. Trans rer 30 ftl of eac h Standard in lirst s ix we ll s. 
6. Transfer 30 JlI of c lear supernatant into the other wel ls 
7. 250 JlI of cholesterol reagent was then added into all the 96 we ll s quick ly using 
Multi-channel pipeltes. 
8. Incubated far 5 minutes at 37°C on orbitalmic rotitcr plate shaker. 
9. Absorbance was read at490 nm . 
Clllcllllliioll 
Optical den sities of standard and unknown samples were fed in to a computer 
programme. Results o f un known samples were calculated extrapo lating stand ard four 
parameter logistic curves lIsing a So lhvarc Kinctical 3. 
Estimation of LDL-cho lcstcrol 
The LDL-Cholesterol level in se rum was calc ulated by using by Friede wald formula 
(Friedwald el a/., 1972). 
Formula 
I 
LDL choleste rol = {Total cho lestero l - (HDL C ho lestero l + - x Triglyce ride)} 
5 
ESlilllllliU/l (If C-peplitfe 
Serum C-pept ide was estimated by an enzy mc lin ked immunosorbent assay (ELISA) 
method us ing kit from DRG Intc rnati onallne .. Germa ny. 
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Prillciple 
The DRG C-peptidc ELI SA kit is based on th e compe titi o n pr in c ipl e and microplate 
separation. An unknown amount o r C-peptiJc presc nt in the sample and li xcd amount of 
C-peptide conjugate co mpete for the binding s ites of a po lyc lona l C-peptide anti serum 
coated onto the we ll s . In a second step an enzyme complex binds to C-peptide co nj ugate . 
The unbound Enzyme complex is washed 01T. Hav ing added the substra te so lution. the 
conce ntrat ion of C-pept ide in the samp les is in verse ly proportiona l to th e opti ca l density 
Ineasurcd. 
Reagellf~· 
I . Microtiter we lls coated with C-peptide a nt iserum 
2. C-peptide co nju ga tes in stab iliz ing bufre r so luti on 
3. Enzymcs complex conta ining Horserad ish pe roxid ase 
4. Refe rences standard set, lyophi lized for 1.0 ml , 5 via ls (0 .2- 16 ng/ml) 
5. Ze ro standa rd or Spec imen diluent (3 ml) 
G. Substrate so lution - TM B (22 ml) 
7. Stop soluti on (0.5 M H2S04) 
8. Wash so lution ( lOX co ncentratcd) 
Material Required 
• A l11 ic rotitre plate reader (450nm) 
• Micropipettes w ith di sposab le tips fo r 100, 200 and I 000 ~tI 
• Abso rbent paper 
• De ioni zed wate r 
Procedure 
I. Des ired numbers o f coated m icrotit re we ll s wcre placed in the ho ldc r. 
2. I 00 ~tI o f C-peptide standa rds we re d ispe nsed into well s . 
3. I 00 ~tI o f samples was d ispensed into selected we ll s . 
4 . The we lls we re incubated for 5 minutes at 1'00 111 temperaturc. 
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5. 200 ~tI arC-peptide co njuga te was d ispensed in to cach wel l. 
6. The plate was incubatcd for 3 hours at room temperature. 
7. The contents oJ"the we ll we re shacked out briskl y. 
8. T he we ll s were rinsed 3 tim cs with diluted wash so lution (400 ftl per IVel l). T he 
we ll s were striked sharp ly on absorbance paper to re moved residual drop lets . 
9. 200 I.tI ofenzyme co mpl ex was di spensed into eac h we ll. 
10. The plate IVas incubated for 60 minutes at roo m temperature without agi tation . 
I I. The co ntents of the we ll s were shacked out briskly. The we ll s were rin sed 5 times 
with di lute wash solut ion (400 ~tI per we ll ). Then th e we ll s we re stroked sharpl y 
on absorbance paper to re move res idual droplets. 
12.200 ).1 1 o f substrate so lution was added to each we ll. 
13. T he plate was incubated for 30 minutes. 
14 . 100 II I o r stop solution IVas added tll each we ll and 
15. Absorbance o f each we ll was determined at 450 nm by us ing a mi crowe ll plate 
reader (B io-Tek, EL-340. USA). 
Determination of insulin secretory capacity and insulin sensitivity 
Homeostas is Mode l Assess me nt (HOMA%S) is a s imple wide ly used method whi ch 
derives se parate indices o r 13 ec ll secre ti on (IIOMA% I3) and in sulin sens iti vity 
(HOMA% S) J"rom the serum glucose and in sulin co nce ntrati ons under basa l co nd it ions 
by us ing mathematica l fo rmula or so ftware (Levy el al .. 1998). The HOMA mode l has 
been incorporated in a s im ple MS-DOS-bascd compute r progra m (HOMA-CIGMi\ 
so ftware) that a ll ows rapid dete rmination o f" % 13 (13 ce ll secretion) and % S (i nsulin 
sens iti vity) from measured values. A lthough the s imple eq uati on gives a qualitati vely 
use fu l approx imation of the mode l prediction. most autho rs prefer the computer mode l. 
In this study HOMA-C IGMA so lhva rc was used. 
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DNA Method 
Extracti on orONA was performed using GenE lute DNA ex traction kit (Q IAGEN . USA) . 
The kit uses the princ ipa l o i" silica ge l DNA iso lati on frolll wh o le blood adapted in spin 
co lumn . 
Equipment, reagent and accessori es 
• Wate r bath 
• Vo rtex 
• Centrifuge 
• Microcentrifuge tubes (1.5 ml ) 
• Pipette tips at di fferent capacit ies ( I 0 ~d. 20 ~d , I 00 ~d , 200 ~d and I 000 ~d) 
• Mieropipetles (4-50 ~d , 100-1 000 ~tI) 
• Abso lute e tha no l (95 -100 %) 
C()//leW oIDNA /iiI 
• Extraction co lul11n 
• Collecti on tubes 
• Proteinase K 
• RNase-A solution 
• Lyses Buffer AL 
• Wash Burfer A W I and A W2 
• Elution BulTer AE 
Preparatio// ()I reage//I,. 
Wash buffer A W J: 125 ml ethano l (96- 100%) was added to obtain 125 ml Buffer A W I 
(95 Illi concentrated). 
Wash buffer A W2: 160 III I ethanol (96-100% ) was added to obta in 226 ml Buffer A W2 
(66 ml concentrated) . 
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Extraction procedure 
I. Frozen blood was brought to room temperature and made homogenous by brief 
vortexing. Aliquot of blood (200 ~t1) was transferred into 1.5 ml microccntrifugc 
tube . 
2. 20 ~t1 QIAGEN prote inase K was added inside the cap of the microcentrifuge tube. 
3. 4 ~d of an RNase-A stock so luti on (I OOmgiml) was added to th e samp le before 
add ing of Buffer AL. 
4. 200 ~I Buffer AL was added to the sample. In order to ensure effi cient lyses, pu lse-
vortexed for 15 sec to make a homogenous so lution. 
5. Incubated at 56°C for 10 min. 
6. To remove drops from the inside of th e lid at the tube brielly centrifuged. 
7. 200 ~ I eth anol (96- 100%) was added to the sample, and mi xed by pu lse-vortexing 
fo r 15 sec and brielly spanned. 
S. The mixture from the step 7 was trall slerred to the QIAamp Mini Spin Column 
(mounted on 2 1111 co llection tu be) without wett ing the rim and a fter clos ing the 
cap, ccntrifuged at 6000 x g for I mill . The QIAamp Mini Spi n column \Vas placed 
on a fresh 2 ml co ll ection tube. 
9. The QIAamp Mini Spin co lumn was opened carefull y and 500 ~I Buffer A W I was 
added without wetting the ril11 . Centrifuged at 6000 x g for I min. the co llection 
tube was discarded and the spin co lumn was placed on fresh co ll ection tu be. 
10. The Q IAal11 p Mini Sp in co lul11n was opened careCully and 500 ,d BuCrer AW2 was 
added without wctting the rim. Cap was sc rewed care full y and the centrifuged at 
20000 x g for 3 minutes. At th is stage the co lumll appeared to be clean. 
II. The QIAamp Mini spin co lul11n placed aga in on a 2 1111 co llect ion tube. 200 ~t1 
Buffer AE was added to the co lumn. Incubated at room temperature for 5 minutes . 
Centri fuged at 6000 x g for I min ute at 25°C. This elute supposed to contain DNA . 
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Check for DNA extraction 
DNA yield for each sample was checked by agarose ge l ( I %) electrophores is. To prepare 
agarose gel, appropriate amount o f agarose was taken into po lypropy lene co nical fl asks 
conta ining required volume o f worki ng tri s-borate EDTA (TBE) buffer. Aga rose in 
work ing TBE buffer was mi xed by swirlin g of th e fl asks. It was then boi led us in g a 
microwave oven at medium temperature. The ge l was coo led nearer to the gel ling po int 
and ethid ium bromide (0.5 ~lg/ml) was added. The ge l was then poured into horizontal ge l 
mould, combs inserted, and a llowed to po lymer ize. The ge l was subscq ucnt ly placed in 
hori zo nta l e lectrophoresis tank till ed with working THE buffer. 
To resolve DNA extract 3 III o f DNA elute mi xcd with appropriatc amount of loading 
buffer and then the mixer was loaded in agarose ge l prepared ea rlier. The gc l was run for 
at medium vo ltage fo r required time. DNA prese nce was visua lized und er UV light and 
gel image was captured. 
Figure 6: Gel image of DNA e lectrophoresis to check the extracti on yield 
Vitamin D receptor (VOR) gene polymorphic markers analyses 
Vitamin 0 receptor (VDR) ge ne po lymorphic mark ers (G>T and T>C) wcre analyzed by 
PC R and RFLP. 
The DNA segment containing G>T (Apa I restricti on) and T>C (Taq I restriction) 
pol ymorphic marker was ampli fi ed using the fo llowing primer set: 
Forward primer: 5' -CAG AGC ATG GAC AGG GAG CAA G-3' 
Reverse primer: 5' -GCA ACT CCT CAT GGC TGA GGT CTC A-3' 
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pe R was carried out in 15 ~d react ion vo lullle. Product sizc for the above mcntioned 
primer set is 740 bp . The PC R protoco l is as fo ll ows: 
Name of (he componcn( Voln me (fill 
DNA 4.00 ~d 
Bu ffer 1.50 fd 
dNTl's 0. 12 fd 
Forward Primer 0.70 pi 
Reverse Primer O. 70 ~d 
HotStar! Taq DNA po lymerase 0. 1 05 ~d 
7.875 fd 
To(al 15.0 fi l 
PC R condition 
Co nccn (ra lion 
10-50 nglml 
lOx 
200 Fma l 
10 pma l 
10 flm o l 
5 U/fd 
Conditions for the amp lilication of the above mention prod uct inc ludc ini tia l stcp of 
denaturation 94°C for 15 min fo llowed by 35 cycles of denaturation at 94°C lor 30 
second s, annealing at 64"C for 45 seconds and e longation at noe to r 45 seconds and a 
35 'h cyc le was fol lowed by a step of final elongati on noe lo r 10 minutes. 
Evo/ualioll of peR 
3 ftl o f PC R product was checked lo r al11p lili cati on in a 1.5 % agarose ge l. The opt imum 
s ize o f the product was ascertaincd comparing it w ith 100 bp DNA ladder. The amplified 
DNA was visualizcd us ing under UV li ght and gel image ca pturcd and doculll cllteci . 
4 1 
740 bp 
Q. 
.0 
Figure 7: Ge l image o r VDR PC R fo r G>T and T>C co nt a ining DNA 
fragment in agarosc ge l 
RFLP analysis of VDR gene candidate markers 
G>T polymorphi sm restri cts Apa l site. Hence the po lymorphism was determined by 
Apa I restriction endonu c lease di gestion. T he di gestion was ca rri ed out in a reac ti on 
vo lume of 1 5 ~d. The enzyme digestion protoco l is as fo ll ows: 
APlll restrictioll CIIZYllle liige.\'lioli protocol: 
Name of thc componcnt Voillme (flll 
PC R prod uct 4 .000 fl l 
Buffe r 1.500 fll 
Restriction enzyme 0. 160 fl l 
BSA 0.200 pi 
Spermidine 0. 187 ~d 
H2O 8.952 ~" 
Total reactioll volume 15.00 fl l 
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Apa I restri ction enzyme digesti on was carricd at 25"C l'or 2 hours in watc r bath . Enzyme 
digcsti on prod uct was rcso lved in 3% agarosc ge l and digestcd product was visuali zed 
us ing ge l documentat ion systcm lo ll ow in g cthidiulll bromidc straining. 
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Figure 8: Agarose ge l imagc of VDR gene Apn I G>T ca ndidate marker 
analys is by Apa I rcstri ct ion cnzymc di gcstion 
T>C polymorph ism crcates a rcstr icti on s ite for Taq I endonuc leasc . Hence the 
pol ymorphi sm was determincd by Tnq I rcstricti on cnzyme di gesti on. Restriction enzyme 
digcsti on was performcd us in g standa rd d igestion protoco l. T he digesti on was carricd out 
in a reacti on vo lume of 1 5 ~d . The enzyme digestion protoco l is as fo ll ows: 
Til'll /'e~·t/'ictioll ellzym e digestioll p/,otocol: 
Name o r the cOlllponent Volume (Ill) 
PC R product 4.000 ~d 
Buffcr 1.500 ~d 
Restricti on enzymc 0.250 III 
BSA 0.200~d 
Spermidinc 0. 187 III 
H,O 8.862 ~LI 
Total reaction volnme J 5.00 III 
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Taq I restriction enzyme digestion was carri ed at 65°C lo r 2 hou rs in water bath. Enzy me 
digesti on product was reso lved in 3% agarose ge l and d igested product was visua li zed 
us ing ge l doc um cntation system lo ll owing cthidium bromide stra inin g. 
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Figure 9: Agarose ge l image of VDR gene Taq I T>C candidatc marker anal ysi s 
by Taq I restriction enzyme di gestion. 
Statistica l Methods 
Data wc re expressed as mean (±SD) and num ber (pe rccntage) as app ropriate. Dirrerence 
between two groups was determined by unpaired Studcnt· s ·t· test, Chi-sCJuare test whe re 
applicab le . Data were managed us in g stat isti ca l package for soc ial sc ience (SPSS) fo r 
Windows Version 10. 
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CHAPTER 4 
RESULTS 
IU-:SULTS 
A total number of 186 unrelated subjects we re included in the study. or them 94 were 
healthy controls and 92 wcre young diabetcs mellitus (YDM). In control group male and 
female di stribution was 55 (58.5%) and 39 (4 1.5%) respectively. In YDM group the 
di st ri bution was 37 (40.2%) and 55 (59.8%) respectively. 
Age, 13M I and blood pressure of the study sulljects 
Mean (±SO) age (yrs) orthe cOlltrol anel YOM subjects was 23±4 alld 19±6 respectively. 
Mean 01' YOM subjects was stati stically sign ificant lower (p<O.OO I) compared to the 
control (Tab le 3). 
Mean (±SD) body mass index (BM I) of the control and YDM subjects was 20.4±3.7 and 
IS.2±5. 1 respectivciy. Mean BMI was stat isti ca lly sign ificant ly lower (p=O.OOI) in the 
YOM group cOlllpared to the contro ls Crable 3). 
Mean (±SO) systolic blood pressure (SBP. Illmllg) of th e control and YOM subjects was 
11 2.4±7.4 and I03.7± 12.4 respecti vely. Mean 513 1' was stati sti cally significantly lower 
(p<O.OO I) in the YOM compared to the controls (Table 3). 
Mean (±SD) diasto li c blood pressure (DBI'. mlllHg) of the control and YDM subjects 
was 71.6,~5 () and 6g.8±9.1 respectivel y. Me'lIl DI3P in thi s two groups did not show 
stati sti c .. I signi Ii cant di ITerenee (IF O. 16) Cra ble 3). 
Anthropometric measurements of the study subjects 
Mean (±SD) mid ann circumference (MAC. em) of the control and YOM Sllbjccts was 
24.4±3.3 and 21.3±5.7 respectivel y. Mean MAC was stati sticall y signili cantl y lower 
(p<O.OOI) in the YDM gro up compared to the contro ls (Table 4). 
Mean (±SD) tri ceps sk in fold (TSF. mill) o fthc con trol and YDM subjccts was 11 .1±5.9 
and I 1.5±S.2 respec ti vely. Mean TSF in tile two gro ups did not show signifi cant 
dilTercnee (1'<0.7 16) Crable 4). 
Mean (±SD) subscapular skin fo ld thickness (SSt' . 111111) o rthe control and YDM subjects 
was 17.2±7.9 and 14.3± I0.5 respectively. Mean SSF was stat isticall y signili cantl y lower 
(p=O.036) in the YDM group compared to the cont rols Crable 4) . 
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Serulll glucose levels allli ill~ulinclllic status of the study subjcct~ 
Mean (±SO) fasting serum g lucose (FSG. mmo l/l) o rthe contro l and YOM subjects was 
4.9±0.5 and 15.5±5.2 respectively. (Tab le 5). 
Mean (±SO) C- peptide va lucs (ng/ml) in the co ntro l and YOM su bjects was 1.6±0.6 and 
1.2±0.9 respecti vely. Mcan C-peptide va llie was stati stica ll y s ignifica ntly lower 
(p<O.OOI) in th e YOM group co mpared to thc contro ls (Tab le 5) . 
Mcan (±SO) of HOM A%S in the contro l and YOM subj ects was 94. 1±39.8 and 
102.6±S3.3 respec ti ve ly. Mea n HOMi\%S va lues was stat istica lly s ignificant ly lowcr 
(p<O.OO I) in the YOM group co mpared to the contro ls (Table 5) . 
Mean (±SO) HOMA% B values in the con tro l and YOM subj ects was 11 2.6±38.5 and 
19A±21.3 respcctivcly. Mean HOMA %13 valuc was stat istica lly s igni fi ca ntly lower 
(p=0.003) in the YOM group compared to the con trols Cra ble 5). 
Mean (±SO) HOMA IR values in the con tro l and YOM subjects was 0.3G±0 .1 5 and 
O.74±0.54 respective ly. Mean HOMA IR valuc was stat istica ll y s ignificantly hi gher 
(p<O.OO I) in the YOM group compared to thc contro ls (Table 5). 
Lipid levels of s tudy subjcct~ 
Mean (±SO) scrum tri glyce rides (TG, mg/d l) o f the contro l and YOM subj ec ts was 
109±48 and 128±57 respecti ve ly. Mean TG was stat isti ca lly s ignifi can tl y hi gher 
(p<O.O 19) in the YOM group compared to the contro ls Crab le 6). 
Mean (±SO) serum tota l cholestero l (mg/d l) o f the contro l and YOM subjccts was 
147±32 and 148±39 respecti ve ly. Mean total cho lesterol in the two genotypes did not 
show stat istical s ignificant difference (p<0.962) Crab le 6). 
Mean (±SO) high dens ity li poprote in cho lesterol (HOL-c, mgldl) o f the control and 
YOM subj ects was 37±8 and 32± IO respecti ve ly. Mean I-IOL-c was stati sti cal ly 
signi fi cant l), lower (p<O.OO I) in the Y OM group compared to the controls (Table G). 
Mean (±SO) low densi ty lipoprote in cho lestero l (LOL-c, mgld l) of the control and YOM 
subj ects were 89±32 and 91±3G respecti ve ly. Mean LOL-c in the groups did not show 
stat isti ca l s ignifica nt difference (p=0.725) (Tab lc 6). 
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Table 3: Age, I3MI and blood press ure of the stud y subjects 
Varia Il les Control (n=94) YI)M (n=92) lip values 
Age (yrs ) 23±4 19±6 4.780/<0.00 1 
13M I (kg/m2) 20.4±3 .7 IS.2± 5. 1 3.355/0.00 I 
SI3P (mmHg) 11 2.4±7.4 103.7± 12.4 5.775/<0.00 I 
1)131' (m Il1H g) 7 I. G±5.9 68 .8-'09.1 2.433/0.16 
Results were expressed as Illcan±SD. 
Stat istica l comparison between groups was performed lIsing unpaired Student 's ' r test. 
BMI, Body Mass Index; SB P, Systoli c Blood Pressure DBP. Diastolic IJl ooci Pressure; YDM. 
Young Diabetes Me llitus. 
Table 4: Anthropometric measureme nts of the stndy snbjects 
Varia Il les Contro l ( 11=94) YDM (11=92) II" values 
MAC (e m) 24.4±3 .3 2 1.3±5.7 4.51 S/<O.OO I 
TSF (mm) 11.1 ± 5.9 11 .5± S.2 0.364/0.7 16 
SSF (111m) 17.2± 7 .9 14.3± 10.5 2.117/0.036 
Results wcre expressed as IIlc<ln±SD. 
St<ltis ti...:al comparison between groups was performeu lIsing unpa ired S tudent's',' tes t. 
MAc' MiJ Anll C ircum fe rences; TS F. Triceps Sk in Fold ; SS F. Sub Scapu lar Skin rold; YDM , 
Youllg Diabetes Me llitus 
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Tablc 5 : Glyccmic and Insulincmic status of the stndy subjects 
Variables Control (n=94) YOM (n=92) lip vailles 
FSG (mmo l/ I) 4.9±0 .5 IS.4±5.2 19 .040/<0.00 I 
C-peptide (ng/ml) 1.6 ±0.6 1.2±0.9 3.297/<0.00 I 
1I0MA 'Yo S 94. 1±39.8 102.6±83.3 6.541/<0.00 I 
110M A % 13 11 2.6 ±3 8.5 19.4±2 1.3 3. 10210.003 
1I0MA lR 0.36±0. 15 0.74±0.54 6.364<0.00 I 
Resul ts were expressed as mean±SD. 
Statistical comparison between groups was perfo rmed using unpaired Student' s' t' test. 
FSG, Fasting Serum Glucose; HOMA%S. Insulin sensitivity assessed by Homeostatic Model 
Assessment; HOMA%B. [l-ce ll function assessed by Homeostat ic Mode l Assessment ; YDM, 
Young Diabetes Mellitus. 
Table 6: Lipid lcvels of the study subjects 
Variables Control (n=94) YOM (n=92) III' vailles 
TG (mg/d l) 109±48 128±57 2.365/0 .019 
T C hol (mg/d l) 147±32 148±39 0.048/0.962 
HOL-e (mgld l) 37±8 32± 10 3.8 10/<0.00 I 
LDL-c (mgldl) 89±32 9 1±36 0.353/0.725 
Results were expressed as mean±SD. 
Stat istical comparison between groups was performed using unpai red Student 's' t' test. 
TG, Triglyeerides; T Chol, Total Cholesterol; HDL-c, High-density Lipoprotein Cho lesterol; 
LDL-c, Low density Lipoprotein Cholesterol , YDM, Young Diabetes Mellitus. 
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CANDIDATE GENE MARKER ANALYSES 
VDR gene G>T (Apa! restriction) variant 
Gcnotype frequ enc ies o f th e VOR gene G>T variants in the contro l gro up we re 0. 183, 
0.51 6 and 0.301 I'or wild type. heterozygo us (Ht ) vari ant and homozygous (Hz) va ri ant 
respecti vciy. In the YO M group. the freq uenc ies were 0.1 98. 0.484 an d 0.3 19 
respecti vely. The genotype frequency in the two groups di d not show stati stica l 
s ignifi cant associati on (;.:2=0 .198; p=0.906) Crable Si). Hardy-We inbe rg distribution o f 
the ge notype frequ ency in the Contro l (;.:2=0.508; p=0.476) and in the YDM group 
(;.:2=0.032. p=0. 859) . For a ll the study subjects th e di stri buti on was (;.:2=0.387; 
p=0.844). Hardy- Weinberg distributor fo und to be in compliance for the ma rker. 
When heterozygous and ho mozygo us va ri ant gc notypes were grouped togeth er, the 
d istr ibution was as fo ll ows: Co ntro l - 0.183 and 0.8 17 for wild and va riant ge notype 
respecti ve ly; YOM - 0.1 98 and 0.802 respecti ve ly whi ch di d not show s ignifi ca nt 
assoc iation (l=0.067; p=0.795) between the two groups (Ta ble 8ii ). Odd -Ratio fo r the 
variant genotype was to the condition 0.907 (ran ge 0.434-1.895), which d id not show any 
s igni ti cant ri sk association (p=0.852J. 
Table 7i: VDR gene Apa\ G>T genotype orthe s tnlly snhjects 
VDR Apa! G>T genotype Control (n= 94) YDM (n= 92) Total (n= 186) 
Wild (GG) 0. 183 ( 17) 0. 198 ( 18) 0. 190 (35) 
Ht variant (GT) O . 5 1 6(4~) 0.4 84 (44) 0.500 (92) 
Hz variant (TT) 0.30 I (25) 0.3 19 (29) 0.3 10(57) 
/ = 0. / 98 p =O.906 
Res ults we re expressed as ti·equency (numbe r). 
Chi-square test was performed to calcul ate statistica l associat ion. 
Hz Wild, homozygous wi ld ; Ht va riant, Heterozygous vari ant; Hz variant. Homozygous 
variant; VDR, Vitamin D rece ptor; YOM. Young Diabetes Me llitus. 
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Tablc 7ii: VDR gene ApaJ G>T gcnotype (Ht and Hz variant together) of the study 
subjects 
VOR Al'a I G>T gcnot)'pc Control (n=94) YOM (n= 92) Total (n= 186) 
Wild GG) 0.1 83 ( 17) 0. 198 ( 18) 0. 190 (35) 
Variant (GT and TT) 0.8 17 (76) 0.802 (73) 0.8 10 ( 149) 
, 
X- = 0.06 7 IF 0. 795 
Results were expressed as frequency (number). 
Chi-square test was per rorlned to cal culate stati sti ca l associati on. 
VDR gene T>C (Taq I restriction) variant 
Genotype frequenc ies of the VDR gene T>C variants were 0.370, 0.522 and 0. 109 lor 
wild type, heterozygous (Ht) vari ant and homozygo us (Hz) var iant respecti vc ly. In the 
YD M group, the frequenc ies we re 0.484, 0.'1 18 and 0.09 respecti ve ly. The genotypc 
frequcncy di str ibution did not show statistica l s ign iJl cant associati on (X2=2 .492; p=0.288) 
(Tab le 9 i). Ha rdy- Wein be rg distributi on of the gcnotype frequency in the Contro l was 
(X2= 1.3 18; p=0.0.25 I ) a nd in the YDM gro up (X2=0.034, p=0.850). Fo r a ll the study 
subj ects the Hardy-Weinberg di stributi on was the fo und to be in equili brium (X2=0.66 J; 
p=OA I6) . Thc T>C gc notype freq uency found to be in complia nce with Hardy- Wein berg 
equ iii bri um . 
When hcterozygous and homozygous variant genotypes we re groupcd togct her, the 
di stribution was as fo llows: Contro l - 0.37 and 0.63 for w il d and variant genotype 
respecti ve ly; YDM - 0 .484 a nd 0.5 16 respecti ve ly wh ich a lso did not show signi fica nt 
assoc iati on (l=2.429; 1'=0. J J 9) between the two groups Crab lc 10). Odd -Rat io for the 
vari ant genotype to the condition was 0.626 (range 0.347- 1.230). whi ch did not show any 
s igni tlcant risk association (p=0.1 36). 
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Table 8i: VDR gene Taq I T >C genotype of the stndy snbjects 
VDR Taql T>C genotype Control (n= 94) YDM (n= 92) Total (n= 186) 
Wild (TT) 0.370 (34) 0.484 (44) 0.426 (78) 
lIt variant (TC) 0.522 (~X) 0.4 18 (38) 0.470 (86) 
Hz variant (CC) 0.109 ( 10) 0.090 (9) 0.104 ( 19) 
/ = 2.-192 p =O.288 
Results were expressed as li'cquency (number). 
Chi-square les t was performed to calculate statisti cal associat ion. 
Hz Wil d. Homozygous wi ld ; Ht voriant, Heterozygous variant; Hz variant , Homozygous 
vari ant; VDR, Vitamin D receptor; YDM. Young Diabetes Mellitus. 
Table 8ii: VDR gene Taq I T>C genotype (Ht ali(I Hz variant together) of 
the study subjects 
VDR Taq I 'J'>C genotype Contro l (n= 94) YI)M (n= 92) Tota l (n= 186) 
Wi ld (TT) 0.370 (34) 0.484 (44) 0.426 (78) 
Variant (TC and CC) 0.630 (58) 0.5 16 (47) 0.574 (105) 
, 
X = 2129 p =O.1J9 
Results were expressed as frequency (number). 
Chi-squa re test was performed to ca lcu late statistical associati on. 
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Glycemic alld illsulillemic status of study subjects 011 the basis of Apa J G>T 
gCllotype 
Mea n (±SO) fasting g lucose leve ls in subjects with wild and variant (heterozygous and 
homozygous together) ge notype in the co ntro l (S. I±0.6 and 4.9±0.S respectively; 
p=0.227) and YOM group (16.2±4 .S and I S .3±S.S respectively; 1'=0.463) (Tab le 9i). 
Mean (±SO) C-peptide leve ls in subj ects with wild and variant (heterozygous and 
homozygous together) genotype in the control was ( I .G±0.7 and I.G±O.G respecti ve ly; 
1'=0.829) and YOM group (0.99±0.83 and 1.28±0.95 respective ly; 1'=0.243) (Tab le 9i). 
Mea n (±SO) HOMA %B in subjects with wi ld and variant (heterozygous and 
homozygous together) genotype was in the con trol was (10 1.0±3 1.6 and II S.0±39.8 
respecti vely; p=0.14G) and in YOM group ( 11 .G± II .6 and 20.9±22.7 respectivcly) (Table 
9i). HOMA%B in the subjects with variant a ll e le was s ignifi cantl y highe r (p=0.0 19) 
compared to th ese with wild a ll e le . 
Mean (±S D) HOMA%S in subj ects with wi ld and variant (heterozygous and 
homozygous together) genotype was found to be a lmost s imilar in the contro l (95.0±30.9 
and 94.1±4 1.8 respectively; p=0.929) as we ll as in YDM group ( 106.5±46.2 and 
102.4±90.7 respecti vely; p=0.8SS) (Tab le 9 i). 
Mean (±SO) insul in res istance in subjects with wi ld and variant (hete rozygous and 
homozygous together) genotype in the con tro l was (0 .3±0.1 and 0.3±0.1 respectively; 
1'=0.9 10) and YDM gro up (0.6±0.6 and 0.7±OA respective ly; p=0.720) (Tab le 9i). 
Mean (±SD) BMI leve ls in subj ects with wild and variant (heterozygous and 
homozygous togeth er) ge notype in the co ntro l was (20.5±2A and 20A±4.1 respective ly; 
p=0.087) and in YDM group ( 16.7±4. 1 and IS.6±5.3 respective ly; p=O.1 08) (Tab le 9ii). 
Mean (±SO) SBP leve ls in subj ects with wild and va ri ant (heterozygous and 
homozygous together) genotype in the contro l was ( I 12.9±G. I and I 12.4± 7.7 
respecti vely; 1'=0.788) and YDM group (9S. I± 11.0 and 104. 1± 12.4 respect ively; 
p=0.035) (Table 9ii). 
Mean (±SD) DBI' levels in subj ects with wild and variant (heterozygous and 
homozygous together) genotype in the contro l was (7 1.7±5.2 and 71.5±6.1 respective ly; 
p=0.886) and YDM group (64 .7±7.7 and 69.7±9.1 respecti ve ly; p=0.035) (Tab le 9ii ). 
Mean (±SO) tri glycerid e leve ls in subjects with wi ld and variant (heterozygous and 
homozygous together) genotype in th e contro l was ( 107.1±36.S and II O. I±S I.I 
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respectively; p~O.840) and YDM group (I06.9±40.2 and 132. 1±60.1 respectively; 
p~O.097) (Table 9ii). 
Mean (±SD) cholesterol levels in subjects with wild and variant (heterozygous and 
homozygous toge ther) genotype in the control was ( 162.1 ±39.2 and 144. 1±3 0.5 
respecti vely; p~0.039) and YDM group (134. 1 ±28. 7 and 150.7±40.7 respectively; 
p~O.1 07) (Table 9ii). 
Mean (±SD) LDL levels in subjects with wil d and variant (heterozygous and 
homozygous together) genotype in the con tro l was ( I 02.7±3 7.7 and 85 .6±30J 
respectively; p~0.048) and YDM group (8 1.2±2 1.7 and 92 .7±38.8 respective ly: p~O.1 02) 
Cfable 9ii). 
53 
Table 9i: G lyccmic a nd insulincmic status of the s tudy subjects on th e basis of Apa I G>T 
genotype 
FSG (m mol/l) C-pcplillc I-IOMA%1l HOMA%S 1·IO:vtA-IR 
( nWIllI ) 
COlllro / subjecls 
W ild 
5.1 ±0.6 1.6±0.7 101 .0±J 1.6 95.0±JO.9 D.H 0. 1 
(n= 17) 
V:lriant 
4.9±0.5 1.6± 0.6 I 15.0±39.8 94.1 ±41.8 0.3±0.1 (n=76) 
1/1' 
1.243/0.227 0.2/9/0.829 / .496/0. 146 0.090/0.929 0.114/0.910 
va/ues 
YDM subjecls 
Wild 
16.2± 4.5 0.9± 0.8 I 1.6± I 1.6 I06.5±46.2 0.6±0.6 
(n=30) 
Va riant 
15.J± 5.5 1.2±.9 20.9±22.7 102A±90.7 0.7±OA 
.(n=71) 
1/1' 
0.637/0.463 1.177/0.243 2. -/2-// (1.0 19 0./83/0.855 0.359/0.720 
values 
Results were expressed as mean±S D. 
Statistical compmison between groups was performed using unpaired Stud en t' s' t' test. 
Variant. heterozygous and homozygo us varillnt together; FSG, fasting serum glucose; PPG, 
postprandial glucose; F insulin. Fasting Insul in; !-IOMA %0. Homeostasis model assessment S-
cell Function; !-I OMA %S, Homeostasis model assessmen t insulin sensitivi ty; YOM Young 
Di abetes Mellitus. 
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Table 9i i: G lycem ic a nd insu linem ic status of th e s tu dy s ubjects 0 11 th e basis of AI'a I 
G>T gellotype 
llM I S ll l' UBI' TG C holesterol LUL 
COlltrol subjects 
W ild 
20.5±2.4 11 2.9±6. 1 71.7±S.2 I07.1 ±36.8 162. 1±39.2 I02.7±37.7 
(n= 17) 
Varhmt 
20.4±4.1 11 2.4±7.7 7 1.5±6. 1 110. 1±51. 1 144 . 1±30.5 8S.6±30J 
(n=76) 
lip 
0.15810.875 0.27010.788 0.1.f310.886 0.20210.840 2.09410.039 2.00310.0·18 
values 
YDM subjeL"ls 
W ild 
16.7±4. 1 98.1 ± 11.0 64.7±7.7 106.9±40.2 134. 1±2S.7 S 1.2±21.7 
(n=30) 
Varia nt 
IS.6±S.3 104. 1± 12.4 69.7±9. 1 132.1 ±60. 1 ISO.7±40.7 92.7±J8.S 
(n=7 1) 
lip 
1.65010.108 2.14310.035 2.13510.035 1.67610.097 1.63110.107 1.66810. 102 
vollies 
Results were expressed as Illcan±SD. 
Statistical comparison between groups was performcd usi ng unpaired Studen t' s't' test. 
Vari ant, heterozygous and homozygo us variant together; BM I, Body Mass Index; S131'. Systolic 
Blood · Pressure; DBI'. Diastolic Blood Pressure; TG. triglyceride; LDL. Low dens ity 
Lipoprotein. 
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Glycemic and insulincmic s tatus of s tudy subj ects on the basis of Taql T>C 
genotype 
Mean (±SO) fasting glucose leve ls in subjects with wild and var iant (heterozygous and 
homozygous together) genotype in the co ntro l was (S.O±O.S and 4 .9±0.5 respective ly; 
p=0. 11 7) and YOM group ( IS.4±S.4 and IS.G±S. I) respecti ve ly; p=0.8 IS) Crab le IOi). 
Mean (±SO) C-pept ide leve ls in subjects with wild and variant (heterozygous and 
homozygous together) genotype in the control was (1.6±0.6 and 1.6±0.6 respect ively; 
p=O.77G) and YOM group ( 1.2±0.9 and 1.2±0.9 respect ively; p=0.922) (Table IOi) . 
Mean (±SO) HOMA%B in subjects with wil d and variant (heterozygous and 
homozygous together) genotype in the contro l was (107.6±40.2 and 114.7±3 7.8 
respectively; p=0.393) and YOM gro up (20.G±24. S and 17.6± 17.9 respect ive ly; p=0.S I2) 
(Table 10i). 
Mean (±SO) HOMA%S in subjects with wild and variant (heterozygo us and 
homozygous together) ge notype in the con tro l was (90.8±3 1.2 and 96.8±44.5 
respectively; p=0.491) and in Y OM group (96.4±60.8 and I 09.4±99. 7 re spectively; 
p=0.0.467) (Tab le 10i). 
Mean (±SO) insulin resista nce in subjects with wild and variant (hete rozygous and 
homozygous together) in the con tro l was (O.3±0. 1 and 0.4±0.1 respective ly; p=0.670) 
and in YOM group (0.7±0.S and 0.8±0.S respectively: p=0.674) Cfab le 10i). 
Mean (±SO) BM I levels in subjects wit h wi ld and variant (heterozygous and 
homozygous together) genotype in the control was ( 19.4±2.S and 2 1.1 ±4. 1 respecti ve ly; 
p=0.046) and YOM group ( IS.I ±5.4 and IS.2±4.9) respectively; p=0.91 0) (Table 10ii). 
Mean (±SO) SBP level s in subj ects with wi ld and variant (heterozygous and 
homozygous together) ge notype was fou nd to be almost s im i lar in the contro l (I 10. I ± 7.9 
and 113.8±6.8 respect ive ly; p=0.02 1) as we ll as in YOM group subj ects ( 100. 1± 10.3 and 
106. 1± 13.4 respecti vely ; p=0.009)(Tablc 10ii). 
Mean (±SO) OBP levels in subjects with wi ld and variant (heterozygous and 
homozygous together) genotype in the contro l was (69.7±S.9 and 72 .7±5.8 respective ly; 
p=0.023) and YOM group (67 .8±9.3 and 69.5±8.8 respectively; p=0.366) (Tab le 10ii). 
Mean (±SO) TG level s in subjects with wi ld and variant (heterozygous and homozygous 
together) genotype in the contro l was ( 108. 1 ±4 1.8 and I I 0.5±S2 .9 respec tively; p=0.82 1) 
and YOM group (120. 1 ±46 .2 and I 33.7±66.3 respect ive ly; p=0.263) (Table 10ii). 
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Mean (±SO) cho lestero l levels in subjects with wild and variant (hete rozygous and 
homozygo us together) geno type in the contro l was (t49.2±34.4 and t45.7±34.9 
respectively; p=O.G27) and YOM group ( 145. 1±36.2 and 149.5±41. 7 respectively; 
p=0.603) (Table 10 ii). 
Mea n (±S D) LDL leve ls III subjects w ith wild and variant (heterozygo us and 
hOIll OLygo uS togethe r) ge no lype in Ihe eO lllro l was (90.60,32.6 and S7.2±32.2 
respectively; p=0.G26) YOM group (89. 1±30.S and 9 1.6±4 I. I respectivel y; p=0.746) 
(Table 10i i). 
Table 10 i: Glycem ic an d illsu line mic s ta tus of (he st udy s ubjec ts on (h e basis of 
Taq I T >C genotype 
FSG 
(mlllo l/l) 
COl/ lrol su bjects 
Wi ld 
S.O±0.5 
(n=34) 
Vnriant 
4.9±0.5 
(n=58) 
lip vallles 1.581/0.11 7 
YOM subjects' 
Wild 
15.4± 5.4 
(n=44) 
Va ria llt 
IS.6± 5. 1 
(n=47) 
IlpVllllles 0.235/0.815 
C-pcpl idc 
(ng/ml) 
1.6±O.6 
1.6±0.6 
0.286/0.776 
1.2± 0.9 
1.2± 0.9 
0.09810.922 
Results were expressed as mean±SD. 
IIOMA'!I"B UOMA %S li t 
107.6±40.2 90.8±3 1.2 0.3±0. 1 
tI4.7±37.8 96.8±44.5 O.4±O. 1 
0.858/0.393 0.69 1/0.491 O. ·/2I:JIO. 6 70 
20.6±24.5 96.4±60.8 0.7±0.S 
17.6± 17.9 109.4±99.7 0.8+0.5 
0.65810.512 0.73110.467 0.42210.674 
Stati sti ca l comparison betwee n groups was performed us ing unpaired Stud ent 's' t' tesl. 
Variant, heterozygous and homozygous varian l toge lh er; FSG. Fasting Se rum Glucosc; HOMA 
%B, HOlllcostasis model asscssmen t B-cell Function; HOMA %S, Homeostasis modc l 
assessment insulin sensitivity. 
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Table 10ii: Glycemic and insulinemie s tatns of the s tudy subjects 011 the bas is of 
Taql T >C genotype 
BMI SBI' DBI' TG C holes terol LDL 
Cuntrol subject:' 
Willi 
19.4±2.8 I IO. I±7.9 69 .7±5.9 I08.1 ±4 1.8 I 49.2±34.4 90 .6±32.6 
(11=34) 
Vuriant 
2 1.1 ±4. 1 11 3.8±6.S n.7±5.S I IO.5±52.9 145.7±34.9 87.2±J2.2 
(11=58) 
III' 
2.024/0.0-16 2.35110.021 2.3061(J.023 0.22710.1121 0.-18 710.62 7 0.-18810.626 
values 
YDM subjects 
Wi ld 
1~. 1 ±5.4 IOO.I ± IO.3 67.8±9.3 120 . 1±46. 1 145.1 ±36.2 89 .1 ±30.8 
(n=44) 
Variant 
IS.2±4.9 I06. 1± 13.4 69.5±8.8 133.7±66.3 149.5±4 1.7 91.6±4 1.1 
(11=47) 
lip 
0.11310.910 2.65110.009 0.90910.366 1. 12 710.263 0.52210.603 0.32510.7-16 
val lies 
Results were expressed as mean±SO. 
Stat ist ica l comparison between groups was performed usi ng unpai red Student' s' t' test. 
Variant , heterozygous a nd homozygous va ri ant together; BM l. body mass index; SBp. systol ic 
blood pressure; DB I' , d iasto lic blood pressure; TG. trig lyce ride: LOL, low dens ity lipoprote in . 
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DISCUSSION 
DISCUSSION 
Oiabetes Mellitus has emerged as a majo r hea lth problem allover the world and is posing 
additional burden to the already exhausted health care budget like many other developing 
countries ineluding Bangladesh. 
Over all the prevalence of diabetes in Bangladesh is 7% (Sayeed et ai., 2007). Majority of 
diabetic patient are of type 2 variety. However, a substan tial number of patients do not fit 
to either to type I or type 2 groups. They are termed as yo ung onset diabetes mellitus 
(YOM). This group of patients mainly encompasses previously termed FCPO and PODM 
patients, who are c1assitied as MROM . 
To characterize the nature of diabetes in thi s group and explore its etiopathogenesis a 
number of studies have been under taken so far. One study involving lean young diabetic 
patients has revealed secretory defects in these subjects (Zinnat et. ai., 2003). 
Subsequently (Hassan et. 01., 2005) in thesis study showed that YOM subjects may be 
representing atyp ical TIOM in Bangladesh. These subjects a lso have been found to 
belong to low insulin secretory group. The hallmark ofT I OM is destruction of pancreatic 
B cell leading to severely compromised insulin secretion resulting in need for insulin for 
metabolic control. 
Vitamin D has been suggested to play an important role in the pathogenesis of diabetes 
mellitus, both in type I and type 2 varieties (Norman et ai. , 1980). Moreover, VDR gene 
polymorphisms have been found to be associated wi th TlDM in different population 
(Yoshiko el ai., 2009). However, studies also revealed lack of association of VOR gene 
polymorphism with either Tl OM or T2DM (Ortlepp et 01., 2003) . 
The lack or presence of association of VOR gene polymorphi sm with diabetes mellitus 
points to the importance of gcne cnvironment and gene to gene interaction in its 
pathogenesis. In this respect ethnic variation appeared to be an important factor. 
The novelty of present study is the inclusion of a group of unique young onset diabetic 
patients for the determination of VDR gene G>T and T>C polymorphism. The YOM 
subjects (n=94) were of low to near normal BMI (18.2±5.16) and matched with control 
(20.4±3 .74) (Table: 3). Male-female distribution in the control and YOM group did not 
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show significant association (p= 0.009). The leanness of the YOM subjects in the present 
study has been further confi rmed by their sign ificantly lower mid-arm circumference and 
sub scapular skin fold thickness (p=O.OOI and 0.036 respectively) compared to the 
controls. 
The YOM subjects in the present study were found to be having low insulin secretory 
capacity as revealed by I-IOMA%B (I 9.4±2 1.3) and I-IOMAIR (0.74±0.S4) values 
compared to the control group. The prcsent finding is in agreement with the observation 
of Ali et aJ., (2003). 
VOR gene polymorphic (O>T and T>C) markers genotype in the present study 
determined were in compliance with the Hardy-Weinberg equi li brium. VOR gene O>T 
polymorphism did not show any association with YOM (X2= 0.1 98; p=0.906). This is in 
agrecmcnt with lchiro et a l (2002) who did not findi ng any assoc iation between VOR 
gene O>T variation and juvenile onset diabetes in the Japanese population. The finding is 
also substantiated by the lack of association in the study involving in Finnish type I 
diabetic patients. They have concluded that single nucleotide polymorphism is unlikely to 
be associated with type I diabetes in Finnish population (Turpeinen el al. , 2003). The 
lack of association of the VOR gene O>T polymorphism in the present study is, however, 
in contrast to that observed in the type 2 diabetic patients (Samiun 2009). Presence of 
wild or variant all ele in the study subjects did not show any difference regarding their 
blood glucose, insulin secretion as evaluated by measurement of C-peptide, in absolute 
term or HOMA-IR. However, YOM subjects with variant allele had significantly higher 
HOMA%B compared to those with wi ld allele. The findings suggest, important 
interaction between insulin gene expression and VOR gene O>T polymorphism 
considering the effect of VOR polymorphism in its expression. 
In the present study VOR gene T>C (Taq I restriction) polymorphism also did not show 
any association with YOM (l= 2.49; p=0.288). Th is is again in agrcement with findings 
of Ichiro et aJ., (2003) in the Japanese population. VOR gene T>C polymorphism also 
lacked any association with type I diabetes in Caucasoid population (Oh and Berrot el 
al., 2002).Presence of VOR gene T>C variant allele also did not show any relationship 
regarding insulin secretory status of pancreatic B ccll in YOM subjects. 
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The lack of any relationship of VOR gene G>T and l > C polymorphism with YOM as a 
group and there insulinemic status docs not exclude poss ible role of other polymorphic 
marker in the pathogenesis or diabetes in the young whieh needs to be evaluated. 
It may be concluded that; (i) VOR gene G>T and T>C polymorphic marker are not 
associated with diabctes mellitus in the yo ung Banglmleshi d iabetic pati ents; (ii ) Insulin 
secretory dysfunction is main feature o f pathogenesis of di abetes in the young; (iii) VOR 
gene G>T genotype is associated with higher secretory capacity however, need to be 
fut1her substantiated. 
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Limitations of the study 
• Small number of young onsct diabetic subjects IS the major weakness of thi s 
study. 
• Measurement of Vitamin D level was not done this would have strengthened the 
data substantiall y. 
Recommcnda tions 
• Thc study needs to be completed involving adequate number of patients to 
provide proper stati stical power. 
• Further study should design to explore the relationship of VDR gene common 
variants with YDM found to be related in other populations. 
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APPENDICES 
Appcndix I 
Data Collection Sheet 
MS Thesis 
I. Idcntitlcation No: 
2. Particulars of thc SUbjccts: 
i) Name .: _______________ ____ _ 
ii) Father's (Husband' s Name :. ____________ _ 
iii ) Age.: ______ years 
iv) Sex: Male I Female 
v) Add ress : 
Present: ______________ _____ _ 
Permanent: __________________ _ 
vi) Phone/Ce ll : _________________ _ 
vii ) Date of I" Exam ination: ____________ _ 
3. Past Mcdical history: 
4. Drug history: 
Anti-HTN: 
Li pid Loweri ng: 
Anti-obes ity: 
Anti-ischemic: 
80 
5. Family history: 
i) ramily history ot'Diabctcs 
ii) Family hi story of HTN 
6. Social history: 
i) Marital status: Marri ed / Unmarried / Widow. 
ii) Scio-economics Status: 
Total members of the family: 
Income of the fam ily (Monthly / Yea rly): 
iii) Educational Status: 
Class I-V III / SSC-HSC I Graduate I Others ,-( _____ ~ 
iv) Occupation: 
Current Designation Duralioll: 
Type of Work 
Profess ional / Housewife / Sa lcs Person / Domestic help / 
Laborer / Others ( ) 
v) Habit: 
Exercise: 
Present (Type , Duration 
Past (Type , Duration 
Not 
Smok ing: 
Present (Duration , StickS/day 
Past (Duration , Sticks/day 
Not 
Betel Lea f: Yes / No ( ) 
) 
) 
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7. Physical Examination: 
(b) Anthropometry: 
( ii ) Height in meter: 
(ii i) Weight in Kg: 
(iv) Waist circum ference: 
(v) Hip circumference: 
(vi) Mid-upper arm circumference (MU PC): 
(v ii ) Sk in fold thickness : 
Triceps: 
Sub-scapular skin fold s thickness: 
(vii i) Body fat mass: 
(b) 13I00d pressure: 
I· reading i ia reading Average read ing 
Systolic 
Diastolic 
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